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 Oropharyngeal candidiasis is an opportunistic infection of the oral cavity caused 
by Candida albicans, a fungal member of the human commensal flora that 
causes disease only under conditions of immunosuppression.  In HIV+ 
individuals, the onset of disease is directly correlated to a decrease in CD4+ T 
cell counts (<200 cells/mm3), suggesting that CD4+ T cells are important 
mediators of anti-Candida immunity.  Previous studies demonstrated that IL-17 
receptor A (IL-17RA) signaling is absolutely required for immunity to OPC.  IL-17 
is produced by a CD4+ T helper cell subset, Th17, and by a variety of innate 
immune cell types.  Although it has always been assumed that CD4+ T cells are 
the primary mediators of immunity to C. albicans, the relative contribution of Th17 
cells in the context of other, innate, sources of IL-17 had never been studied until 
now.  We demonstrate that protective, antigen-specific Th17 cells develop upon 
secondary infection with C. albicans and contribute to fungal clearance from the 
tongue.  Surprisingly, in the absence of CD4+ T cells, compensatory sources of 
IL-17, such as CD8+ T cells and CD3+CD4-CD8-, protect susceptible hosts from 
OPC.  Our findings have important implications for designing vaccines targeted 
to immune compromised populations where it is necessary to harness residual 
immunity.  
INTERLEUKIN-17-MEDIATED ADAPTIVE IMMUNITY TO CANDIDA 
ALBICANS IN OROPHARYNGEAL CANDIDIASIS 
Nydiaris Hernández-Santos, Ph.D. 
University of Pittsburgh, 2012
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1.0    INTRODUCTION 
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1.1 CANDIDA ALBICANS AND CANDIDIASIS 
C. albicans is a commensal fungus of the human microflora that possesses the ability to 
undergo morphological transitions from yeast to filamentous forms (pseudohyphae and 
hyphae) as a result of changes in environmental factors such as temperature.  Although 
C. albicans is normally a harmless inhabitant of human mucosal surfaces, it causes 
disease as a result of breached mucosae, immune suppression or changes in the 
surrounding microenvironment (Akpan and Morgan, 2002).  Candidiasis is classified in 
two major disease types, disseminated and mucocutaneous.  Disseminated disease is a 
consequence of uncontrolled mucosal infection or damaged mucosal surfaces.  It 
exhibits a mortality rate of approximately 40% (Wisplinghoff et al., 2004) and thus 
represents a significant health care problem.  Chronic mucocutaneous candidiasis 
(CMC) includes infections of the skin, nails, vaginal tract (vulvovaginal candidiasis, 
VVC) and oral cavity (oropharyngeal candidiasis, OPC, “thrush”).  CMC is mainly a 
consequence of impaired immune responses due to genetic deficiencies, HIV infection 
or administration of immunosuppressive drugs (chemotherapy, transplant recipients), 
although it is known that VVC commonly affects immune competent women.  
Of the spectrum of mucocutaneous infections, OPC is particularly interesting due 
to the strong and well-documented correlation between compromised host immune 
mechanisms and the onset of disease.  In fact, approximately 95% of HIV+ individuals 
exhibit overt thrush lesions, which consist of pseudomembranous plaques in the tongue, 
buccal mucosa, palate, periodontal tissues and oropharynx (Akpan and Morgan, 2002; 
Fidel, 2011).  The onset of OPC in HIV+ patients is associated with CD4+ T cell counts 
below 200 cells/mm3 (Wright and Johnson, 1997), strongly suggesting that CD4+ T cell 
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responses are vital for host defense against C. albicans.  The role of CD4+ T cells in 
host defense against C. albicans has gained considerable attention in recent years and 
it is the central topic of this dissertation. 
1.2 IMMUNITY TO CANDIDA ALBICANS 
1.2.1 Recognition of fungal pathogen associated molecular patterns (PAMPs) 
and the priming of adaptive immune responses. 
In recent years we have witnessed tremendous advances in our knowledge of how the 
immune system responds to fungal pathogens.  Specifically, several pattern recognition 
receptor (PRR) pathways of fungal recognition and the type of T cell responses that 
they prime have been described.  Most fungal PRR recognize components of the C. 
albicans cell wall, which is a complex array of layered proteins and carbohydrates (Gow, 
2012) (Figure 1.1).  Candida albicans is a dimorphic fungus, existing in yeast (conidia) 
or hyphal (filamentous) forms.  The outer portion of the Candida cell wall is largely 
composed of mannan and manoproteins, and the inner layer is composed of !-(1,3)-
glucan and chitin moieties.  Expression of cell wall proteins and carbohydrates is 
significantly altered during the yeast to hyphal transition, which occurs when the fungus 
invades target organs.  The immune system, by virtue of distinct PRRs, can distinguish 
these fungal forms, in ways that are beginning to be unraveled.  Accumulating evidence 
demonstrates that PRR engagement by C. albicans in antigen presenting cells (APCs) 
results in secretion of specific cytokines including IL-1!, IL-23 and IL-6 (Gow, 2012; 
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Netea et al., 2008; Romani, 2011).  These cytokines in turn promote skewing of 
activated CD4+ T cells into the Th17 lineage, which express IL-17 (also known as IL-
17A), IL-17F and IL-22.  IL-17 and IL-17F are closely related cytokines that signal 
through a common receptor (composed of the IL-17RA and IL-17RC subunits), and IL-
17R signaling is clearly crucial for effective anti-Candida immunity (Conti and Gaffen, 
2010) (Figure 1.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: C. albicans cell wall and PRRs.  The cell wall of C. albicans is 
composed of proteins and carbohydrates arranged in layers.  The outer layer 
consists of mannoproteins and mannan, which is recognized by a variety of PRR 
including dectin-2, mincle, MR and TLR4.  The middle layer is composed of "-
glucan, which is recognized by dectin-1.  Finally, the bottom layer is made of chitin 
for which the PRR has not been identified.  Due to its location in the outer layer, 
mannan is more accessible to the immune system than "-glucan or chitin and it is 
particularly abundant in the hyphal form.  "-glucan is buried underneath the 
mannan layer but it can be exposed in “bud scars”.    
Printed with permission from Cell Host & Microbe  
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Figure 1.2: C. albicans recognition by antigen presenting cells and the 
generation of antifungal Th17 responses.  Upon C. albicans infection, 
components of the cell wall are recognized by PRR on the surface of APC.  This 
triggers a series of signaling events including kinases and adaptor molecules 
like Syk and CARD9, which results in the translocation of NF%B to the nucleus 
and the production of pro-inflammatory cytokines.  Pattern recognition also 
activates NLRP3 and NLRC4 inflammasomes leading to IL-1" production.  Pro-
inflammatory cytokines such as IL-6, IL-23 and IL-1" result in the generation of 
Th17 cells that produce IL-17, which can then bind to its receptor on epithelial 
cells and trigger the production of antimicrobial peptides and neutrophil 
recruiting chemokines.  
Printed with permission from Cell Host & Microbe  
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1.2.1.1 Toll-like Receptors (TLR) 
 
Of the Toll-like receptors, TLR2 and TLR4 are the major participants in C. albicans 
recognition.  TLR2 binds to phospholipomannans and "-glucan (the major component of 
yeast zymosan), and acts in combination with dectin-1 to induce pro-inflammatory 
responses in a variety of Candida infection settings (Hise et al., 2009; Netea, 2006; 
Villamon et al., 2004; Yuan and Wilhelmus, 2010) (Figure 1.1, 1.2A).  TLR2 has also 
been shown to suppress inflammatory responses to Candida via production of IL-10 and 
enhanced Treg survival.  Accordingly, TLR2-/- mice are more resistant to disseminated 
candidiasis than WT, supporting a detrimental rather than protective role for this 
receptor (Netea et al., 2004).  On the other hand, TLR4 recognizes C. albicans O-linked 
mannan and stimulates production of the inflammatory cytokine TNF" in human 
mononuclear cells and murine macrophages.  TLR4-/- mice exhibited increased 
susceptibility to disseminated candidiasis (Netea et al., 2002). Although TLR9, TLR1 
and TLR6 are also implicated in recognizing Candida pathogen associated molecular 
patterns (PAMPs), none are required for immunity to this organism (Netea et al., 2008; 
van de Veerdonk et al., 2008).  Mice deficient in MyD88, an adaptor central to TLR 
signaling, are sensitive to Candida infection, which supports a role for either TLRs or 
alternatively IL-1 family cytokines (Bellocchio et al., 2004).  However, humans with 
MyD88 defects do not appear to be particularly prone to fungal infections (von Bernuth 
et al., 2008).  Thus, other pathways of pattern recognition are important in C. albicans 
immune sensing and the subsequent priming of T helper cell responses.  Alternatively, 
this paradox may indicate a difference in how mice and humans sense this organism. 
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1.2.1.2 C-type lectin Receptors (CLR) 
 
The CLR have garnered considerable attention in the context of Candida, and appear to 
be comparatively more critical than TLR for immunity in both mouse models and 
humans (Saijo and Iwakura, 2011; Vautier et al., 2010).  The best-characterized CLR 
with respect to Candida are dectin-1, dectin-2 and mincle (Figure 1.2).  Although details 
of their respective signaling pathways are still being elucidated, they all appear to 
mediate signaling through the kinase Syk1, the adaptors CARD9/Bcl-10/MALT1 and the 
NF-#B and Ras/Raf-1 pathways (Gow, 2012; Willment and Brown, 2008).  Dectin-2 and 
Mincle form heteromeric complexes with the Fc$R, whereas Dectin-1 does not engage 
this subunit.  Recently, the kinase PKC% was shown to be activated by dectin-1 and 
induce phosphorylation of CARD9.  Both CARD9-/- and PKC%-/- mice are susceptible to 
disseminated candidiasis (LeibundGut-Landmann et al., 2007; Strasser et al., 2012).  
The CLR DC-SIGN in human dendritic cells (DCs) is involved in mediating Candida 
uptake via recognition of N-linked mannan (Cambi et al., 2008; Takahara et al., 2012).  
Although the role of DC-SIGN in the generation of Th17 responses during C. albicans 
infection is unclear, it appears to inhibit dectin-1-dependent Th17 generation and 
instead favor Th1 responses in a model of tuberculosis (Zenaro et al., 2009).  Similarly, 
the lectin Galectin 3 also recognizes Candida (Brown, 2010; Gow, 2012; Netea et al., 
2008).  Although the specific contribution of this receptor to antifungal immunity is not 
well defined, a recent study showed that Galectin 3 associates with dectin-1 and 
contributes to TNF! production in macrophages (Esteban et al., 2011).  Exactly how 
signals from these disparate CLRs are integrated is still not fully understood. 
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Dectin-1 recognizes the "-(1,3)-glucan, which is usually buried underneath a 
layer of cell wall proteins and mannan moieties, posing an issue of accessibility for 
innate immune cells (Figure 1.1).  Nevertheless, "-glucan is exposed in bud scars that 
are revealed during the process of hyphal transition, which facilitates Candida 
recognition and may be the essential signal that alerts the host of a transition from 
fungal colonization to infection (Netea et al., 2008).  Consistently, dectin-1-deficient 
mice exhibit impaired production of inflammatory cytokines such as IL-6 and 
granulocyte-colony stimulating factor (G-CSF) (Taylor et al., 2007), which drive Th17 
differentiation and are induced upon IL-17 signaling (Gaffen, 2009), respectively (Figure 
1.2).  Furthermore, "-glucan stimulation of bone marrow dendritic cells (BMDCs) 
promotes skewing of Th17 cell differentiation, thus linking CLR signaling and activation 
of a Th17 response (LeibundGut-Landmann et al., 2007).  
However, the role of dectin-1 in fungal host defense remains a topic of debate.  
Whereas one study showed that dectin-1-/- mice showed increased susceptibility to 
disseminated candidiasis (Saijo et al., 2007; Taylor et al., 2007) another report found 
that dectin-1-/- mice were resistant.  Intriguingly, in the study by Saijo et al., dectin-1-/- 
mice were susceptible to Pneumocystis carinii, suggesting that the role of dectin-1 in 
antifungal immunity may be pathogen-specific.  In addition to promoting Th17 
responses, dectin-1 signaling appears to play a role in balancing the frequencies of Th1 
and Th17 cells.  Specifically, the absence of dectin-1 during lung infection with 
Aspergillus fumigatus causes reduced production of IFN# and T-bet, a transcription 
factor that controls Th1 differentiation, resulting in decreased Th1 responses and 
correspondingly enhanced Th17 differentiation (Rivera, 2011).  Therefore, !-glucan 
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recognition by dectin-1 shapes the overall nature of antifungal CD4+ T helper 
responses.  As described in detail below, dectin-1-deficient humans with chronic 
mucocutaneous candidiasis (CMC) have been identified, supporting the idea that 
dectin-1 is a bona fide recognition element for Candida (Table 1.1).  However, disease 
in these patients was generally mild, and the mutation was later found to be a fairly 
common polymorphism linked to Candida colonization in transplant recipients (Plantinga 
et al., 2009).  Thus, PRRs other than dectin-1 probably play central roles in immunity to 
Candida. 
Dectin-2 recognizes N-linked mannan sugars, which are localized in the exterior 
layer of the yeast cell wall (Robinson et al., 2009), and appears to be especially 
important in recognition of hyphae (Bi et al., 2010).  Similar to dectin-1, stimulation of 
BMDCs via dectin-2 triggers Th17 differentiation.  C. albicans-specific Th17 cells are 
diminished more dramatically in the absence of dectin-2 than in the absence of dectin-1 
(Robinson et al., 2009).  However, not all studies of dectin-2 in antifungal host defense 
are consistent.  One report showed that antibody blockade of dectin-2 in dectin-1-/- 
mice led to reduced IL-17 production during systemic Candida infections.  Surprisingly, 
however, diminished IL-17 production did not correlate with disseminated disease as 
assessed by kidney fungal burden (Robinson et al., 2009).  In contrast, dectin 2-/- mice 
were found to be more susceptible to disseminated candidiasis than WT mice (Saijo et 
al., 2010).  The basis for these discrepancies was attributed to different observation 
periods and disease kinetics, but may also indicate that additional elements are 
involved in host immunity to Candida.  While dectin-1 and dectin-2 recognize different 
components of the Candida cell wall and thus may preferentially “see” yeast versus 
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hyphal forms of the microbe, in vivo studies have not yet fully clarified which CLR is 
more important.  Ultimately, it is likely that signaling through a multiplicity of PRRs is 
needed to develop an optimal immune response. 
In addition to dectins, mincle and the mannose receptor (MR) recognize mannan 
carbohydrates from Candida (Figure 1.1). In human peripheral blood mononuclear cells 
(PBMC), mannan was found to induce more IL-17 than other fungal PAMP such as "-
glucan and chitin (van de Veerdonk et al., 2009), perhaps indicating a dominant role for 
MR in this process.  Interestingly, this study also demonstrated MR-dependent 
production of IL-17 in cells from dectin-1-deficient patients, supporting the idea that 
stimulation of MR by C. albicans is potentially a primary pathway for the generation of 
antigen-specific Th17 responses.  Mincle binds to the mycobacterial component 
Trehalose-6,6-dimycolate (TDM) and its synthetic analogue Trehalose-6,6-dibehenate 
(TDB), and induces Th1 and Th17 responses in a Syk- and CARD9-dependent manner 
(Ishikawa et al., 2009; Schoenen et al., 2010; Werninghaus et al., 2009).  This suggests 
that fungal cell wall components such as !-mannans may induce Th17 responses via 
mincle.  Interestingly, whereas mincle-deficient mice are susceptible to disseminated 
candidiasis (Wells et al., 2008), MR-deficient mice are resistant (Lee, 2003), arguing 
that the MR is redundant with CLRs in terms of mediating anti-Candida immunity. 
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1.2.1.3 The inflammasome 
 
The intracellular inflammasome has emerged as another PRR in antifungal host 
defense.  Composed of cytosolic Nod-like receptors (NLRs), notably NLRP1, NLRP3 
and NLRC4, complexed with several adaptors and proteases, the inflammasome 
activates caspase-1 and thereby permits cleavage and secretion of the proinflammatory 
cytokines IL-1" and IL-18.  While neither the cytosolic receptors NOD1 nor NOD2 are 
Table 1.1: Human genetic deficiencies associated with CMC. 
 
(Ferwerda et 
al., 2009) 
(Glocker et 
al., 2009) 
(Ma et al., 2008; 
Milner et al., 2008) 
(Minegishi, 2006) 
(Puel, 2011) 
(Liu et al., 2011; 
Veerdonk, 2011) 
 (Kisand et al., 2010; 
Puel et al., 2010) 
(Puel, 2011) 
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required for Candida recognition (van der Graaf et al., 2006), inflammasomes are 
involved.  Mice deficient in the IL-1 receptor (IL-1R) or apoptosis associated speck-like 
protein (ASC), an essential subunit of the inflammasome, exhibit increased oral fungal 
burdens in a model of oral mucosal candidiasis (Hise et al., 2009).  Fungal 
dissemination in this model was even more pronounced than mucosal infection.  
Consistent with this concept, NLRP3-/- mice are susceptible to disseminated 
candidiasis as well as mucosal disease (Gross et al., 2009).  Elegant bone marrow 
chimera experiments confirmed the role of the NLRP3 inflammasome in preventing 
Candida dissemination, and further demonstrated that the NLRC4 inflammasome 
compartment was also involved in oral C. albicans host infections (Tomalka et al., 
2011).  Notably, NLRP3 is required in hematopoietic cells, whereas NLRC4 functions at 
the level of the mucosal stroma.  Moreover, both NLRP3 and NLRC4 deficiencies 
resulted in decreased expression of IL-17, IL-17F and also one of the IL-17 receptor 
subunits (IL-17RA), directly linking the inflammasomes and IL-17 (Tomalka et al., 2011).  
Furthermore, BMDCs from ASC-/- and caspase-1-/- mice exhibited impaired production 
of IL-1" and IL-18 following Candida exposure, which are important for Th17 and Th1 
development, respectively.  Indeed, splenocytes from IL-1"- and IL-18-deficient mice 
exhibited impaired production of IL-17 and IFN# in response to stimulation from Candida 
(van de Veerdonk et al., 2011).  The development of protective Th17 responses via 
inflammasome activation resulted from the recognition of C. albicans hyphae by human 
macrophages.  The yeast form did not activate the inflammasome, demonstrating that 
this pathway is likely important for discriminating between colonizing yeast and invasive 
hyphae (Cheng et al., 2011).  
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Recently, another member of the NLR family, NLRP10, was demonstrated to 
play a role in host defense against disseminated candidiasis (Joly et al., 2012).  
NLRP10-mediated anti-Candida immunity depended on induction of protective T cell 
responses, presumably Th1- and Th17- mediated as indicated by decreased IFN# and 
IL-17 production from NLRP10-/- splenocytes re-stimulated in vitro with HK C. albicans.  
The absence of NLRP10 did not affect the production of IL-1", indicating that C. 
albicans recognition by NLRP10 does not affect IL-1" production by NLRP3 and NLRC4 
inflammasomes. 
In addition to the role of the NLRP3 and NLRC4 inflammasomes in processing 
pro-IL-1", a recent study identified dectin-1-dependent activation of a non-canonical 
caspase-8 inflammasome (Gringhuis et al., 2012).  Dectin-1 engagement resulted in the 
activation of Syk and the transcription of the IL-1! gene through the CARD9-Bcl10-
MALT1 complex (Figure 1.2).  Recruitment of MALT1-caspase-8 and ASC to this 
scaffold resulted in processing of pro-IL-1" to mature IL-1".  The activation of this non-
canonical pathway did not require C. albicans internalization, whereas activation of 
NLRP3 inflammasome was completely dependent on internalization.  Interestingly, 
some C. albicans strains trigger IL-1" production primarily via caspase-8 while others 
also activate the NLRP3 inflammasome, suggesting that the ligand for NLRP3 is not 
present in all fungi.  It would be of interest to determine the role of the caspase-8 
inflammasome in the development of Th17 responses, but that was not addressed in 
this study. 
Taken together, the priming of host-protective Th17 responses is likely a 
combined effort of multiple PRR pathways that recognize different components of C. 
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albicans, and trigger the production of cytokines that predominantly direct Th17 
differentiation.  Nuances of how different fungal PAMP trigger different PRR is an area 
that requires more development, and subtle alterations of the host response may ensue 
depending on the specific substrain of Candida that is involved and the anatomic site of 
infection. 
1.2.2 T cell responses to C. albicans. 
1.2.2.1 Life before IL-17 was all about Th1 cells 
 
HIV+ individuals are exquisitely susceptible to many opportunistic fungal pathogens, 
including oral thrush.  Importantly, the development of opportunistic infections in HIV 
patients strongly correlates with loss of CD4+ T lymphocytes, indicating that cytokines 
produced by CD4+ T cells are important in immunity to Candida (Akpan and Morgan, 
2002).  Early studies aimed at elucidating the role of CD4+ T cells in host defense 
against C. albicans employed a mouse model of gastric infection.  In this setting, both 
IFN#- and IL-5-producing CD4+ T cells, indicative of Th1 and Th2, respectively, were 
found in Peyer’s Patches and mesenteric lymph nodes, and corresponded with fungal 
clearance. Furthermore, neutralization of IL-4 resulted in increased IFN# production and 
enhanced yeast clearance (Cenci et al., 1995).  These data were interpreted to mean 
that protective antifungal immunity is attributable to Th1 cells, even though hallmark 
cytokines of both Th1 and Th2 lineages were produced during infection (Cenci et al., 
1998; Cenci et al., 1995).  Since these studies occurred prior to the recognition of the 
 15 
Th17 population, the alternative interpretation that non-Th1/Th2 lineages might be 
involved was not considered. 
Studies in a mouse model of OPC showed that nude (T cell deficient) mice were 
susceptible to infection, but could be protected by transfer of CD4+ T cells (Farah et al., 
2002a). Th1-related cytokines, including IFN$ and TNF", but not Th2 cytokines were 
expressed in the oral tissue, consistent with a Th1-biased response (Farah et al., 
2002b). Interestingly, however, depletion of CD4 or CD8 T cells in a susceptible mouse 
strain did not exacerbate oral colonization with Candida (Ashman et al., 2003), although 
adoptive transfer of Candida-specific T cells did induce protection from a disseminated 
challenge (Sieck et al., 1993).  Thus, both innate cells and CD4 cells were implicated in 
immunity to OPC, although the specific subset and cytokines were still not well clarified. 
 
1.2.2.2 Life after IL-17 is all about Th17 cells 
 
The discovery of Th17 cells (Harrington et al., 2005) and the role of IL-23 in their 
homeostasis (McGeachy et al., 2009) have contributed tremendously to our 
understanding of the host immune responses to fungal pathogens.  Prior to this 
important discovery, immunity to most pathogens was attributed to either Th1 or Th2 
cells.  Since Th2 responses were thought to promote fungal pathogenesis, investigative 
efforts focused on elucidating how Th1 cells defended the host against infection.  Most 
of these studies were conducted using mice lacking p40, which is a subunit of IL-12, an 
important cytokine for the differentiation of Th1 cells.  However, it was later 
demonstrated that IL-12 shares the p40 subunit with IL-23 (Ghilardi and Ouyang, 2007), 
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which is paramount for the expansion and pathogenicity of Th17 cells (Lee et al., 2012; 
McGeachy et al., 2009).  Therefore, antifungal immune responses initially attributed to 
Th1 cells may have in fact been Th17 driven.  
A role for the IL-17 axis in antifungal host defense was first shown in 2004, in 
which IL-17RA-deficient mice inoculated i.v. with C. albicans exhibited decreased 
survival and increased kidney fungal burden compared to WT counterparts (Huang et 
al., 2004).  Although disputed in one report (Zelante et al., 2007), most data are 
consistent with a protective role for IL-17 in systemic candidemia.  Furthermore, an 
experimental vaccine containing the C. albicans adhesin protein Als3p and aluminium 
hydroxide as an adjuvant conferred protection against systemic candidiasis via 
induction of both Th17 and Th1 responses (Lin, 2009).  
In a model of OPC, mice lacking Th1 effector cytokines IFN# or TNF" were 
resistant to oral infection, yet mice lacking IL-12p40 were found to be susceptible (Farah 
et al., 2006), suggesting a role for protective IL-23-dependent pathways. In a direct test 
of this hypothesis, our laboratory showed that IL-23p19-/- mice subjected to OPC 
exhibited overt thrush lesions and elevated fungal burdens whereas IL-12p35-/- mice 
did not.  High susceptibility was also observed in IL-17RA-/- and IL-17RC-/- mice, 
implicating the IL-17 pathway directly (Conti et al., 2009; Ho et al., 2010).  Furthermore, 
in extended time courses, IL-17RA-/- mice never recovered from Candida infection, 
whereas IL-12p35-/- mice fully cleared the microbe, albeit delayed compared to WT 
mice.  
Parallel findings were made in mouse models of dermal candidiasis, in which IL-
17 and IL-23 but not IL-12 were essential for immunity to Candida (Kagami et al., 2010).  
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A detailed study of skin-resident DC subsets showed that Th17 cells against Candida 
are generated specifically by presentation from Langerhans cells. Interestingly, 
generation of Th17 cells is blocked by signals from Langerin+ dermal DCs in favor of 
Th1 cells (Igyarto et al., 2011).  In a vaginal candidiasis model, treating with 
halofuginone, which specifically blocks Th17 differentiation, resulted in a profound 
decrease in IL-17 production that correlated with an increase in fungal burden (Pietrella 
et al., 2011).  Thus, similar to disseminated candidemia, mouse models of skin and 
mucosal candidiasis implicate IL-17 and IL-23 in immunity to Candida.  
In addition to Th17 cells, there is an unexpected interplay between Th17 cells 
and regulatory T cells (Tregs), a subset of immunoregulatory T cells, suggesting both 
are required for effective host responses to Candida. Th17 and Treg cells both arise 
from signals from TGF! (although this is still somewhat controversial) (Ghoreschi et al., 
2010), with IL-6 and IL-1! providing the inflammatory switch that favors Th17 cells, and 
IL-2 driving Tregs and preventing Th17 differentiation (Laurence et al., 2007; Yang et 
al., 2011).  Rag-/- mice, which lack both T and B cells, are extremely susceptible to 
OPC.  However, transfer of naïve or Th17-polarized T effector cells alone is insufficient 
to mediate host defense to OPC; rather, co-transfer of regulatory T cells resulted in 
enhanced Th17 responses that were needed to prevent development of OPC. 
Mechanistically, this was shown to be due to a sequestration of IL-2 by Tregs via the 
high affinity IL-2 receptor complex.  Consistently, depletion of Tregs in mice increases 
susceptibility to OPC (Pandiyan et al., 2011).  This finding is in agreement with an 
earlier report that demonstrated a positive correlation between the levels of IL-17 
produced by curdlan-stimulated BMDCs and the ratio of Treg to T effector cells 
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(LeibundGut-Landmann et al., 2007).  Interestingly, stimulation of BMDC with curdlan 
triggered conversion of Foxp3+IL-17- cells into IL-17-expressing Foxp3+ cells (Osorio et 
al., 2008), suggesting that dectin-1 enhances a Th17 response by converting Tregs.  
Thus Tregs play a previously unappreciated protective role in inflammatory responses 
during C. albicans infection. 
Intriguingly, C. albicans appears to actively target the IL-17 pathway, presumably 
as an evasive strategy. Whereas heat-killed Candida stimulated PBMC secrete IL-17, 
co-culture with live Candida strongly suppresses IL-17 production. This factor is 
apparently soluble (and thus far, unidentified), because live Candida exerted this 
suppressive effect even when separated from PMBC in a trans-well system. The 
mechanism appears to be via regulation of tryptophan metabolism.  Specifically, 
suppression of IL-17 observed in co-culture was associated with reduced L-kynurenine 
(an indoleamine 2,3-dioxygenase [IDO]-dependent metabolite, representing one 
pathway of tryptophan metabolism) and increased 5-hydroxytryptophan (representing 
the alternate pathway).  Consistently, ectopic application of 5-hydroxytryptophan 
inhibited IL-17 production (Cheng et al., 2010).  Another recent report suggests that IL-
17 might directly bind to Candida and induce nutrient starvation conditions in the 
organism (Zelante et al., 2012).  Thus, there is still much to learn about the intricate 
interactions occurring between Candida and its host. 
In addition to IL-17A, other Th17-derived cytokines such as IL-17F and IL-22 may 
participate in anti-Candida immunity.  In contrast to IL-17A-/- mice, IL-17F knockouts 
are resistant to systemic candidiasis (Saijo et al., 2010), although the role of IL-17F in 
experimental mucosal candidiasis has not yet been evaluated.  As noted in Table 1.1, 
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dominant negative mutations in IL-17F in humans are linked to CMC, although the 
mutations affect IL-17A as well as IL-17F signaling (Puel, 2011).  Surprisingly, IL-22-/- 
mice inoculated orally with C. albicans had a significantly lower fungal burden than IL-
17RA-/- or IL-23-/- mice, despite the observation that IL-22 mRNA is strongly induced in 
WT mice following oral Candida infection (Conti et al., 2009).  Similarly, in dermal 
candidiasis there was no major role for IL-22 (Kagami et al., 2010).  However, De Luca 
et al. reported that IL-22-/- mice are susceptible to both systemic and gastric 
candidiasis, due in part to impaired production of antimicrobial peptides (AMPs) such as 
S100A8, S100A9, RegIII" and RegIII#.  In addition, blockade of IFN# in IL-22-/- mice 
resulted in fungal dissemination, suggesting that IL-22 together with IFN$ may provide a 
first line of defense in preventing dissemination from the gastric mucosa (De Luca et al., 
2010).  In a recent study where human keratinocytes were infected in vitro with C. 
albicans, IL-22 in combination with TNF! led to decreased cell death and epidermal 
damage caused by infection (Eyerich et al., 2011).  However, IL-22 is impaired in 
several human CMC syndromes (Table 1.1), and thus its role in human candidiasis 
cannot be ruled out.  
Most of the studies in experimental candidiasis have described a protective role 
for IL-17 in host responses to C. albicans.  However, a detrimental role of this cytokine 
has also been reported, specifically in a model of gastric candidiasis.  IL-23p19-/- and 
IL-12/IL-23p40-/- mice inoculated intragastrically with C. albicans showed 100% survival 
over a 2 week period, whereas only 25% of IL-12p35-/- mice survived.  Furthermore, 
expression of IL-12p70 and IFN# in stomach correlated with protection in IL-23-/- mice, 
whereas levels of IL-23p19 and IL-17 were linked to severity of disease (Zelante et al., 
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2007).  Candida does colonize the gut, but the clinical relevance of the gastric 
candidiasis disease model is unclear.  Although some cases of gastric candidiasis have 
been reported, they are extremely rare due to the low pH and inhospitable conditions of 
the stomach (Filler, 2012).  Regardless, these studies indicate that lessons of immunity 
in the gut mucosa cannot necessarily be applied to other sites. 
1.3 “EXPERIMENTS OF NATURE”: HUMAN GENETIC DEFICIENCIES 
ASSOCIATED WITH CHRONIC MUCOCUTANEOUS CANDIDIASIS. 
The identification of Th17 cells and CLR as elements of anti-fungal immunity facilitated 
characterization of human genetic deficiencies underlying development of CMC, either 
in isolation (CMC disease) or in the context of an immune disorder (Table 1.1).  The 
most direct link of IL-17 to the etiology of CMC disease comes from a recent report 
describing rare human pedigrees with mutations in the IL-17 signaling axis. One 
individual had an autosomal recessive mutation in IL-17RA, and cells from this patient 
did not express the receptor and hence were refractory to IL-17 signaling.  Another 
cohort exhibited an autosomal dominant mutation in IL-17F that prevents signaling 
through IL-17A, IL-17F and the IL-17A/F heterodimer (Puel, 2011).  In separate studies, 
gain of function mutations in signal transducer and activator of transcription (STAT) 1 
were identified as causes of CMC disease, and were associated with reduced Th17 
frequency (Liu et al., 2011; Veerdonk, 2011).  It is not fully clear why this STAT1 
mutation causes CMC and reduced Th17 cell numbers, but STAT1-activating cytokines 
such as IFN!/", IFN# and IL-27 are all inhibitors of Th17 differentiation, and accordingly 
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Th17 cells appear to be abnormally restrained in these patients.  
In scenarios where CMC is present in conjunction with other infections and/or 
inflammatory defects, identifying a single cause for recurrent candidiasis poses a 
challenge. Strikingly, in many cases defects in some component of Th17 differentiation 
or the pattern recognition pathways that promote it have been linked to disease.  For 
example, Hyper IgE (Job’s) Syndrome (HIES) patients suffer from recurrent 
Staphylococcus aureus and C. albicans infections, and exhibit a Th17 deficiency due to 
dominant negative mutations in STAT3 (Ma et al., 2008; Milner et al., 2008; Minegishi et 
al., 2007)(Ma et al., 2008; Milner et al., 2008; Minegishi et al., 2007) STAT3 is critical for 
Th17 differentiation in mice (Chen et al., 2006; Yang et al., 2007), as it lies is 
downstream of signaling by IL-23, IL-21 and IL-6 (all involved in induction and 
maintenance of Th17 cells) as well as IL-22 (produced by Th17 cells). Although a failure 
to differentiate Th17 cells is one obvious cause of their susceptibility to Candida, these 
patients also have impaired antifungal activity of saliva (Conti et al., 2011), and their 
keratinocytes show defective responses to Th17 cytokines (Minegishi et al., 2007). 
Mutations in the PRR pathway have also been identified that cause CMC, 
reinforcing results from knockout mouse studies. Some CMC patients show deficiencies 
in CARD9 or dectin-1.  Notably, the dectin-1 mutation appears to be a polymorphism 
found in a population-wide search in individuals from both Europe and Africa and is 
associated with increased Candida colonization in immunosuppressed hematopoietic 
stem cell transplant recipients (Ferwerda et al., 2009; Glocker et al., 2009; Plantinga et 
al., 2009).  
Another cohort of patients with CMC have autoimmune polyendocrinopathy 
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syndrome -1, characterized by genetic defects in central tolerance due to mutations the 
transcription factor AIRE (Brown, 2010).  The cause of CMC in APS-1 was enigmatic, 
until it was discovered in 2010 that these patients produce neutralizing autoantibodies 
against Th17 cytokines, namely IL-17A, IL-17F and IL-22 (Kisand et al., 2010; Puel et 
al.).  These observations, together with the fact that the majority of C. albicans-specific 
T cells in human peripheral blood exhibit a classical Th17 phenotype (Acosta-Rodriguez 
et al., 2007), strongly support a crucial role for Th17 cells in immunity to C. albicans. 
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2.0  CHAPTER TWO: METHODS 
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2.1 MICE 
All mice used in these studies were ordered from The Jackson Laboratories (Bar 
Harbor, ME) in the C57BL/6 background unless otherwise indicated.  IL-23 (p19)-/- mice 
were bred in-house and acquired from Genentech (San Francisco, CA).  In all 
experiments, mice were matched according to gender and age, which ranged from 5 to 
6 weeks.  Animal protocols were approved by the University of Pittsburgh IACUC, and 
adhered to guidelines in the Guide for the Care and Use of Laboratory Animals of the 
NIH.  
2.2 C. ALBICANS GROWTH AND CULTURE CONDITIONS 
For infection (Figure 2.1) and in-vitro cultures (Figure 2.2) C. albicans (strains CAF2-1, 
CAYC2QTPU1 and CJN1348) was grown overnight (approximately 16 hours) in YPD 
broth at 30°C with continuous agitation.  For quantification of fungal burden in the 
tongue following infection, tissue homogenates were plated in YPD agar containing 
ampicillin and incubated at 30°C for 48 hours. 
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2.3 RECALL MODEL OF OPC 
Mice were inoculated sublingually with C. albicans by placing a 0.0025g cotton ball 
saturated in a 2x107 CFU/ml cell suspension underneath the tongue for 75 minutes.  
Sham infections were performed in parallel using a cotton ball saturated in PBS.  This 
procedure was performed under anesthesia, which consisted of 100 mg/kg Ketamine 
and 10 mg/kg Xylazine mixed in saline (0.9% NaCl).  Mice received 1ml of saline both 
before and after the 75 minutes inoculation period.  Secondary infection was performed 
6 weeks later exactly as described above.  At days 1,2,3 and 5 post re-challenge, one 
half of the tongue was homogenize by mechanical disruption using a GentleMACS 
Dissociator (Miltenyi Biotec) and plated in triplicate for colony enumeration.  The other 
half of the tongue was preserved in RNA later (Ambion) and frozen at -80°C for 
subsequent RNA extraction and real-time PCR.  The cLN were also harvested and 
homogenized manually by mechanical disruption.  The resulting single cell suspension 
was analyzed by flow cytometry or cultured in vitro with heat-killed (HK) C. albicans for 
quantification of cytokine levels by ELISA (eBioscience).  A schematic of this infection 
model is presented in Figure 2.1. 
 26 
Figure 2.1: Recall model of OPC.  Mice were infected two consecutive times with 
the same dose of C. albicas (2 x 107 CFU/ml) leaving an interval of 6 weeks in 
between infections.  At days 1-5 after re-challenge the indicated tissues were 
harvested for assessment of fungal burden and cytokine production.  
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4 IN VITRO CULTURE OF CERVICAL LYMPH NODE CELLS WITH C. 
ALBICANS AND QUANTIFICATION OF CYTOKINES 
One million cLN cells were plated in flat-bottom 24-well plates and stimulated with 2 x 
106 HK C. albicans yeasts or 5-10µg/ml pALS (NH2- KGLNDWNYPVSSESFSYT - 
COOH) in the presence or absence of 5µg/ml anti-CD4 (clone RM4-5, BD Biosciences) 
or 10µg/ml anti-MHC class II blocking antibodies (Figure 2.2).  Co-cultures were 
incubated at 37°C and 5% CO2 for 5 days.  Following incubation, culture supernatants 
were harvested and analyzed for IL-17 and IFN# levels by ELISA according to the 
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Figure 2.2: In vitro culture of cLN cells with HK C. albicans.  Three to five days 
following re-challenge, cLN were harvested and homogenized to obtain single-cell 
suspensions.  1 x 106 cLN cells were plated and stimulated with 2 x 106 HK C. 
albicans or pALS +/- anti-CD4 or anti-MHC class II.  5 days after stimulation 
supernatants were collected and the concentration of IL-17 and IFN# were 
measured by ELISA.   
manufacturer’s instructions (eBioscience).  HK C. albicans was prepared by boiling 1ml 
of overnight culture for 45 minutes.  These experiments were performed in serum-free 
AIM V media (GIBCO Invitrogen) containing 1X "-Mercaptoethanol (1000X 
concentrated, 55mM, GIBCO Invitrogen) and 20U/ml of IL-2. 
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2.5 FLOW CYTOMETRY 
One million cLN cells were rested overnight at 37°C and 5% CO2 in serum-free AIM V 
media containing 1X "-Mercaptoethanol and 20U/ml of IL-2.  Cells were subsequently 
stimulated with 50 ng/ml PMA and 500 ng/ml Ionomycin in the presence of Golgi Plug 
(BD Biosciences) for 4 hours at 37°C and 5% CO2.  Following stimulation, cells were 
stained for CD3 APC-Cy7 (clone 145-2C11), CD4 FITC (clone GK1.5), CD8 PerCP 
(clone 53-6.7), CD44 eFluor 450 (clone IM7), CD27 APC (clone LG.7F9), TCR" (clone 
H57-597) and TCR$ (clone eBio GL3).  IL-17 and IFN# were detected after cell fixation 
and permeabilization according to the instructions of the Intracellular Staining Kit (BD 
Biosciences).  Although in the majority of experiments cytokines were detected by 
intracellular cytokine staining (ICS), in certain occasions intracellular IL-17 and IFN# 
were stained with Miltenyi Cytokine Secretion Assay (Miltenyi Biotec) according to the 
manufacturer’s protocol.  A comparison of both methods is depicted in Figure 2.3.  
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Figure 2.3: Comparison between ICS and Miltenyi Cytokine Secretion Assay.  
Mice were re-challenged as in Figure 2.1 and cLN were harvested for 
assessment of cytokine production by ICS and Miltenyi Cytokine Secretion Assay.  
The frequency of IL-17+ and IFN#+ cells among CD4+ and CD8+ T cells is 
presented.  Cells were gated on lymphocytes, CD3+ cells and CD4+ or CD8+ 
cells.  Each point represents the data acquired from 1 mouse.  The S indicates 
Sham and I indicates Infected.     
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Figure 2.4: Scheme of CD4+ and CD8+ T cell depletion. CD4+ and CD8+ T cells 
were depleted alone or simultaneously at the indicated time points with 100-200µg 
of anti-CD4 and/or anti-CD8 antibodies.  Depletion of the appropriate cell subsets 
was verified in spleen cell suspensions by flow cytometry. 
2.6 DEPLETION OF CD4+ AND CD8+ T CELLS 
WT, CD4-/- and CD8-/- mice were infected and re-challenged as described above 
(Figure 2.1).  Depleting antibodies to CD4 and CD8, and the appropriate isotype 
controls, were administered i.p. at days -3 (200 µg) -2 (100 µg) and -1 (100 µg)  relative 
to re-challenge (day 0) in 100 – 200 µl of sterile PBS (Figure 2.4).  Antibodies were 
received from BioXCell and reconstituted in sterile PBS at 1 mg/ml.  Depletion of the 
appropriate T cell subsets was verified by flow cytometric analysis of CD4 and CD8 
expression on the surface of splenocytes and cLN cells.  This depletion protocol was 
kindly provided by Dr. Kyle C. McKenna from the Department of Ophthalmology at the 
University of Pittsburgh.  
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2.7 ADOPTIVE TRANSFER 
WT and CD4-/- mice were subjected to re-challenge (Figure 2.1) and cLN were 
subsequently harvested 3 days later.  CD4+, CD8+ and CD4-CD8- (DN) cells were 
purified from the cLN by positive selection using magnetic beads (Miltenyi Biotec) 
according to the manufacturer’s protocol.  Ten million CD4+ and CD8+ cells or 2 x 107 
DN cells were transferred i.p. into Rag1-/- mice in 200 20000 i.pr’s protocol.  Ten million 
CD4+ and CD8+C. albicans.  Four days following primary infection, the tongue of Rag1-
/- recipients was harvested for quantification of fungal burden and gene expression 
(Figure 2.5). 
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Figure 2.5: Adoptive transfer of CD4+, CD8+ and DN cells.  WT and CD4-/- 
mice were re-challenged and CD4+, CD8+ and DN cells were isolated from cLN 
by magnetic sorting.  Cell fractions were then transferred into Rag1-/- mice i.p. 1 
day prior to infection with C. albicans.  Four days after transfer tongue tissue 
was harvested to enumerate C. albicans colonies and measure gene 
expression.   
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2.8 REAL-TIME PCR 
Frozen tongue tissue preserved in RNA later was homogenized in 500µl of RLT Lysis 
Buffer (RNAeasy Kit, Qiagen) using a GentleMACS Dissociator (M-tubes, RNA-02 
program, Miltenyi Biotec).  The lysates were then collected by centrifugation at 2000 
rpm, 25°C for 2 minutes and RNA was subsequently extracted according to the 
instructions of the RNAeasy Kit.  1ently extracted according to the instrucDNA with the 
SuperScript III First-Strand Sythesis System (Invitrogen Carlsbad CA).  Relative 
quantitation of gene expression was then performed with SYBR Green (Quanta 
BioSciences, Inc.) technology.  GAPDH was used as a housekeeping gene to normalize 
threshold cycle (CT) values.  All primers, unless otherwise indicated, were from SA 
Biosciences (Qiagen Valencia, CA).  TCRl primers were ordered from Eurofins MWG 
Operon and their sequence from 5’èromreads as follows TCRd forward 
TAGTCACACAGGAGAGTTTTCC, TCRd reverse CTTTATTGTCTGCTTGGAGAGC.  
Results were analyzed on a 7300 Real Time PCR System (Applied Biosystems 
Carlsbad, CA).  mRNA expression was calculated using the 2-expr method. 
2.9 GENERATION OF OVALBUMIN-EXPRESSING CANDIDA 
The strategy employed for the generation of Candida-OVA is depicted in Figure 2.6.  
OVA was fused to SSA2, a cell wall protein that interacts with Histatin 5, a component 
of human saliva with potent antifungal activity.  First, the OVA sequence was optimized 
for codon usage in C. albicans, where CTG is decoded as serine instead of the 
 34 
universal leucine (Massey et al., 2003). The optimized OVA sequence was then ligated 
to the 61bp sequence before the stop codon at the 5’ end of SSA2, to allow for 
subsequent homologous recombination.  The synthesis and optimization of the OVA 
sequence, and subsequent ligation to 61bp SSA2, was performed by GeneArt 
(Germany).  Second, the optimized sequence was inserted into a yeast vector 
containing the ADH1 transcriptional terminator and the orotidine-5’-monophosphate 
decarboxylase (URA3) gene, which is responsible for uridine synthesis and it was 
therefore used as a selection marker.  Third, the 67bp sequence after the stop codon at 
the end of SSA2 was added by PCR at the 3’ end of the recombination cassette.  
Primer sequence 5’èsynthesis and it was therefore used as a selection marker.  Third, 
the 67bp sequence a after the stop codon at the end of SSA2 was added by PCR a 
Recombination cassette was amplified with TaKaRa Prime STAR HS DNA Polymerase 
(TAKARA BIO INC) (Figure 2.6B) under the cycling conditions depicted in Table 2.1.  
Finally, URA3 negative strain CAF4-2 was transformed with the recombination cassette 
(Figure 2.6A) and positive clones were selected in media (YNB) deprived of uridine.  
Yeast transformation was performed according to the instructions of the Zymo Research 
Frozen-EZ Yeast Transformation Kit II.  In order to verify integration of the 
recombination cassette into the genome, DNA was then extracted from URA+ 
transformants with Puregene Yeast/Bac. Kit B (Qiagen) and the junction region between 
the recombination cassette and the genomic SSA2 sequence was amplified (Figure 
2.6C).  PCR was carried out with TaKaRa Prime STAR HS DNA Polymerase and 
following the cycling conditions depicted in Table 2.1 modifying the extension time to 1 
minute.  Primer sequences are depicted in Table 2.2.  The clones that integrated the 
 35 
recombination cassette into the genome were lysed for quantification of OVA protein 
expression.  
 
 
Figure 2.6: Generation of Candida-OVA. (A) Strategy employed in the generation of 
Candida-OVA.  (B) PCR product after addition of 67bp of the SSA2 sequence at the 3’ end of 
the recombination cassette. (C) Integration into the host genome was verified by amplification 
of a segment in the OVA sequence (primer pair 1 and left panel) or a sequence including the 
region upstream the recombination cassette and the OVA sequence (primer pair 2 and right 
panel). The positive control in the left panel is a plasmid containing the OVA sequence. The 
negative control in the right panel is Candida-GFP because GFP is located in the same 
position as OVA in Candida-OVA and therefore, should not be amplified. 1011B-1-2, 1-3, 1-4, 
and 3-8 represent individual clones. (D) OVA protein expression was verified by ELISA 
performed with yeast cell lysates generated by mechanical disruption with glass beads. 
A. 
B. 
C. 
D.
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Table 2.2: Sequence of primers used to verify integration of OVA protein in 
the Candida genome. 
Table 2.1: PCR cycling conditions for amplification of recombination cassette 
with TaKaRa Prime STAR HS DNA Polymerase. 
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2.10 YEAST CELL LYSATES    
Yeast cell lysates were prepared by mechanical disruption with glass beads. 425-600 
µe acid-washed glass beads (Sigma) were mixed with overnight yeast culture at a 1:1 
ratio in lysis buffer (20mM Hepes pH 7.4, 150mM NaCl and Np40) containing protease 
inhibitor cocktail (Roche).  Yeasts were then lysed via continuous cycles of vigorous 
agitation (vortex, 30 seconds) and cooling (ice, 30 seconds).  Agitation and cooling 
cycle was repeated 8 times.  The protein content in the lysates was measured using the 
Bradford technique and the Bio-Rad Protein Assay.  Lysates were then aliquoted and 
stored at -80°C. 
2.11 OVALBUMIN ELISA 
Ovalbumin expression was verified by ELISA.  A 96 well plate was coated overnight at 
4°C with 100h  per well of goat IgG fraction to chicken egg albumin (MP 
Biomedicals) diluted 1:1000 in PBS.  Plate was then washed 3 times with 200Pl/well of 
PBS/Tween 20 (diluted 1:2000).  100nSA.  A 96 well plasate was added to each well 
and incubated for 2 hours at room temperature.  The lysate was subsequently aspirated 
and the plate washed 5 times with PBS/Tween and once with PBS.  Non-specific 
binding was blocked with 100µl/well of 5% milk for 1 hour at room temperature.  Milk 
was removed by washing 2 times with PBS/Tween.  100µo/well of polyclonal rabbit IgG 
fraction to chicken egg albumin (MP Biomedicals) diluted 1:100,000 in PBS were 
added and incubated at room temperature for 2 hours.  Primary antibody excess was 
 38 
removed by washing 5 times with PBS/Tween.  To allow detection of ovalbumin-bound 
primary antibody, horseradish peroxidase-conjugated donkey anti-rabbit IgG was 
diluted in PBS 1:2500 (Jackson Immuno Research Laboratories) and 100e /well were 
added and subsequently incubated at room temperature for 1 hour.  The excess of 
enzyme-conjugated antibody was removed by washing with PBS/Tween 2 times and 
with PBS 3 times.  100Th/well of horseradish peroxidase substrate (TMB Stabilized 
Chromogen, Invitrogen) were added and incubated for 30 minutes at room temperature 
and protected from light.  The colorimetric enzymatic solution was terminated with stop 
solution (Invitrogen) and absorbance was measure at 450nm wavelength with a 540nm 
correction.  ELISA protocol was adapted from the instructions kindly provided by Dr. 
Robert Binder from the Department of Immunology at the University of Pittsburgh. 
2.12 CFSE LABELING AND PROLIFERATION ASSAY 
Pooled lymph node and spleen cells from OTII transgenic mice were labeled with 1 µo 
Carboxyfluorescein diacetate Succinimidyl Ester (CFSE) (Molecular Probes, Invitrogen) 
by mixing the cells with CFSE (described in Figure 2.7) diluted in PBS to the 
appropriate concentration followed by a 15 minutes incubation period at 37°C.  To 
remove the unbound CFSE, cold FBS was added to the CFSE-labeled cell suspension 
at a 1:1 ratio and incubated on ice for 5 minutes.  Cells were then pelleted (1,500 rpm, 
4°C, 5 minutes) and washed once in complete RPMI1640 containing 10% FBS, L-
glutamine and antibiotics (Penicillin and Streptomycin).  Subsequently, 10ml of pre-
warmed, complete RPMI 1640 were added to the cells followed by a 30 minute 
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incubation at 37°C.  Cells were then collected by centrifugation (1,500 rpm, room 
temperature, 5 minutes) and resuspended in complete RPMI 1640 at a density of 2 x 
106 cells/ml.  100ls/ml.  of the CFSE-labeled cells were plated in round-bottom 96-well 
plates and subsequently stimulated with ~1.5 x 106 HK Candida-OVA cells or the 
parental URA- strain CAF4-2.  HK Candida was prepared as described in section 2.4.  
As positive and negative controls cells were stimulated with 20 As p of OVA323-339 
(AnaSpec) or left without stimulus, respectively.  CFSE-labeled OTII cells were 
incubated in the presence of stimulus for 5 days at 37°C and 5% CO2.  We then 
proceeded to analyze the cells by flow cytometry. 
 
 
 
 
 
 
C
FSE Proliferation 
Figure 2.7: Carboxyfluorescein diacetate succinimidyl ester (CFSE) mechanism 
of action.  CFSE is colorless until it enters the intracellular space where its acetate 
groups are cleaved by intracellular esterases yielding a highly fluorescent green dye.  
The succinimydil group reacts with intracellular amines, forming stable CFSE-protein 
complexes.  The remaining unbound dye diffuses outside the cell, where it can be 
washed away.  Due to the binding of CFSE to intracellular proteins, it is diluted 2 fold 
with every cell division as the total protein content of the cell splits in half.  This makes 
CFSE a powerful tool to track cellular proliferation as the concentration of dye 
decreases.  
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In one occasion the proliferation assay was performed with purified CD11c+ cells 
and CFSE-labeled CD4+ T cells.  In this case, OTII spleens and LN were perfused or 
bathed with a 2mg/ml solution of collagenase D  and incubated at 37°C for 30 minutes.  
The tissue was subsequently homogenized by mechanical disruption.  In order to 
acquire enough numbers of total cells the lymph nodes and spleens of 3 OTII mice were 
pooled.  CD4+ and CD11c+ cells were then purified by magnetic sorting using negative 
and positive selection, respectively.  Labeling with magnetic beads and subsequent 
sorting were performed according to the manufacturer’s instructions (Miltenyi Biotec). 
1x105 CD11c+ and CFSE-labeled CD4+ T cells were plated and stimulated with 1x106 
HK Candida and incubated for 5 days, which was followed by flow cytometric analysis. 
In a separate experiment we tested the proliferation of OTII cells upon stimulation 
with live Candida-OVA.  2 x 105 live Candida-OVA cells were added to 2 x 105 CFSE-
labeled total spleen and lymph node cells in the presence of 5µg/ml of fluconazole in 
order to avoid yeast overgrowth.  The fluconazole was added after 2 hours of incubation 
at 37°C and left in the culture media for the entire 5-day incubation period. 
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2.13 HISTOLOGY 
Tongue tissue was preserved in 10% NBF, parafilm embedded, sectioned and stained 
with hematoxylin and eosin (H&E) and periodic acid schiff (PAS).  In order to observe 
neutrophils and C. albicans in the same lesions, serial sections were obtained and one 
section was stained with H&E and the following section with PAS.  Tissue sectioning 
and staining were performed by the Research Histology Services located in the 15th 
floor of the Thomas E. Starzl Biomedical Science Tower. 
2.14 STATISTICS 
Unless otherwise indicated, all data was analyzed with a two-tailed unpaired t test using 
the Wilcoxon Mann-Whitney correction.  Statistically significant differences are indicated 
by *p<0.05. 
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3.0  CHAPTER 3: C. ALBICANS RE-CHALLENGE INDUCES LONG-TERM 
PROTECTIVE TH17 IMMUNITY 
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3.1 BACKGROUND 
In recent years accumulating evidence from clinical studies has demonstrated an 
undeniable association between CMC and genetic defects in the IL-17/Th17 pathway 
(Figure 1.2 and Table 1.1), indicating Th17-mediated responses are crucial in host 
defense against C. albicans.  In addition, we have observed that C. albicans persists in 
IL-23-/- mice 21 days after inoculation (Figure 3.1) suggesting that in the absence of IL-
23, which is instrumental for the maintenance of Th17 cells, C. albicans establishes 
chronic infection.  Moreover, Rag1-/- mice, which lack functional B and T cells, are 
susceptible to OPC (Pandiyan et al., 2011).  These data strongly suggest a role for 
“classical” Th17 cells in host defense to OPC. 
However, IL-17 production is not an exclusive function of Th17 cells; several 
innate sources have been described and are summarized in Table 3.1 (Cua and Tato, 
2010).  For example, #$ T cells are potent IL-17 producers at mucosal surfaces. 
Interestingly, they express dectin-1 (Martin et al., 2009), which is important for the 
recognition of "-glucan, a component of the C. albicans cell wall.  It is important to 
consider that the anatomy and physiology of the immune system in the oral mucosa has 
not been described in detail, although there is evidence from human studies suggesting 
the existence of oral immune foci (Cutler and Jotwani, 2006).  It is not known if these 
innate sources of IL-17 are present in the tongue at steady state and whether they play 
a role in response to C. albicans infection.  In support of the notion of innate IL-17 
sources during OPC are the findings that both IL-17 (Figure 3.2) and its target genes 
(CXCL1, CXCL5, S100A8, etc.) were detected in the tongue as early as 24 hours 
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following infection (Conti et al., 2009), suggesting that an innate source(s) of IL-17 plays 
an important role in host defense during OPC.  
In light of these data, the goal of the experiments outlined in this chapter was to 
define the role of “classic” Th17 cells in immunity to C. albicans relative to innate 
responses during OPC.  
 
Table 3-1: Innate sources of IL-17  
 
Adapted from Daniel J. Cua and Cristina M. Tato, Nature Reviews Immunology, 2010  
(Hayday, 2009; 
Lochner et al., 2008; Martin 
et al., 2009; Sutton et al., 
2009) 
(Doisne et al., 
2009; Hayday, 2009; Michel 
et al., 2008) 
(Cella et al., 2009; Crellin 
et al., 2010; Luci et al., 2009; Sanos 
and Diefenbach, 2010; Satoh-
Takayama et al., 2010; Satoh-
Takayama et al., 2008) 
(Buonocore et al., 2010; 
Colonna, 2009; Cupedo et al., 
2009; Takatori et al., 2009) 
(Buonocore et al., 
2010) 
(Takahashi et al., 
2008) 
(Ferretti et al., 
2003; Li et al., 2010; 
Werner et al., 2011) (Neutrophils) 
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Figure 3.1:  C. albicans establishes persistent infection in IL-23-/- mice.  
Mice were inoculated with C. albicans and the tongue tissue was harvested for 
colony enumeration 21 days following infection. 
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Figure 3.2:  IL-17 expression in tongue tissue following primary infection.  
WT mice were sham or C. albicans infected and the tongue tissue was harvested 
at days 1-5 post-infection for subsequent RNA extraction and PCR.  IL-17A was 
amplified from tongue cDNA via traditional PCR (A) or real-time PCR (B).  IL-
17A-specific amplification was verified via the dissociation curve method, which 
yielded a single peak.  
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3.2 RESULTS 
3.2.1 Pre-exposure to C. albicans results in accelerated fungal clearance. 
In order to study the specific contribution of adaptive immune responses to fungal 
clearance, we developed a recall model of infection (Figure 2.1).  Since C. albicans is 
not a commensal microbe in mice, this approach also allowed us to better model the 
human condition, where C. albicans is a component of the normal flora in mucosal 
surfaces.  Experimental cohorts were designed to compare tongue fungal burdens 
between mice that received 1° infection alone or both 1° and 2° challenge.  We 
hypothesized that upon pre-exposure to C. albicans we would observe accelerated 
fungal clearance due to the development of long-term protective immunity.  As 
expected, mice that received 1° and 2° infections experienced accelerate fungal 
clearance at days 1 and 2 post re-challenge, as demonstrated by a ~1 log decrease in 
tongue fungal burden (Figure 3.3).  Infection was cleared by day 3 regardless of 
whether or not mice were pre-exposed to C. albicans.  These data indicated that 
adaptive immune responses contribute to fungal clearance in OPC. 
3.2.2 Accelerated fungal clearance correlates with increased frequency of 
CD4+IL-17+ (Th17) but not CD4+IFN" (Th1) cells. 
The important contribution of adaptive immune responses to C. albicans in OPC 
prompted us to study in detail the nature of the CD4+ T helper cell response responsible 
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for fungal clearance.  To this end, mice were given 1° and 2° infection and cLN were 
subsequently harvested at days 1, 2 and 3 post-re-challenge.  CD4+IL-17+ (Th17) cells 
were first detected 3 days after re-challenge in both mice that received 1° infection 
alone or followed by 2° challenge (Figure 3.4A).  Importantly, the frequency of Th17 
cells was significantly increased in mice subjected to re-challenge when compared to 
mice that solely received 1° infection (Figure 3.4B), indicating the expansion of Th17 
cells upon a second encounter with C. albicans.  We did not detect CD4+IFN#+ (Th1) 
cells at any time point following re-challenge.  Therefore Th17, but not Th1, cells are 
induced upon C. albicans re-challenge and are associated with decreased fungal 
clearance. 
3.2.3 Th17 cells induced upon re-challenge exhibit an activated phenotype 
A recent study in memory CD4 T cells induced after Lysteria monocytogenes infection 
showed that Th17 cells lacked expression of CD27, which has been shown in memory 
CD8+ T cells to be associated with a short life span.  These observations suggested 
that memory Th17 cells are short-lived.  Furthermore, adoptive transfer of CD4+CD27-
CD44+ or CD4+CD27+CD44+ cells from L. monocytogenes-infected mice into naïve 
hosts resulted in 80% decrease of CD4+CD27-CD44+ cells whereas 
CD4+CD27+CD44+ cells survived 14 days after transfer (Pepper et al., 2010).  
However, a different study showed that, in spite of their lack of CD27 expression, Th17 
cells were long-lived, exhibited “stem-cell-like” features and were functional against 
tumors (Muranski et al., 2011).  Regardless of the differences in the longevity of Th17 
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cells, which is likely due to variations in the immunological milieu where they exert 
effector functions, Th17 cells appear to be CD27 negative.  
Thus, in order to gain insight into the phenotype of C. albicans-specific Th17 cells 
induced upon re-challenge we examined expression of CD27 in combination with CD44, 
which is an indicator of T cell activation.  We observed that the majority of C. albicans-
specific Th17 cells were CD27-CD44+ (Figure 3.5), suggesting an activated, effector 
phenotype. 
3.2.4 CD4+ T cells are the primary source of IL-17 during recall responses and 
are antigen-specific.  
CD4+ T cells are not the only possible source of IL-17 in the lymph node 
microenvironment.  It has been demonstrated that CD8+ T cells can produce IL-17 
(Tc17) and are induced upon influenza and vaccinia virus infections, although their 
cytotoxic activity is debated (Yeh et al., 2010; Zou et al., 2011).  Therefore, we 
examined IL-17 production by CD4+ and CD8+ T cells in cLN following re-challenge.  
CD4+, but not CD8+, T cells produced IL-17 upon 2° infection (Figure 3.6A-B), 
indicating that CD4+ T cells are the primary source of Il-17 during re-challenge.  We 
also detected an infection-dependent increase of IFN# production in the CD8+ T cell 
population but it appeared not to be a stable phenotype since it was observed only at 
day 3 post re-challenge and was completely undetectable by day 5 (Figure 3.6B). 
The facts that CD4+IL-17+ cells are detectable only after re-challenge and are 
completely absent in mice that received a sham infection suggested that these Th17 
cells were antigen-specific.  In order to explore this in more detail, we re-stimulated cLN 
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cells in vitro with heat killed (HK) C. albicans or an ALS peptide (pALS), which is a 
sequence of the C. albicans ALS1/3 adhesins and was recently shown to be a CD4+ T 
cell epitope (Bar et al., 2012).  We also included C. albicans strain CJN 1348 (Nobile et 
al., 2008), which lack the ALS1/3 proteins (depicted as ALS-/-), and the appropriate 
isogenic WT strain (CAYC2QTPU1, depicted as ALS+/+).  In addition, to determine if 
these responses were CD4 and MHC II- dependent, we stimulated the cells in the 
presence or absence of blocking antibodies (Bar et al., 2012; Scurlock et al., 2011).  
The data showed that cLN cells produced IL-17 in a CD4- and MHC class II-dependent 
manner in response to WT HK C. albicans and the pALS peptide.  The cells did not 
produce IL-17 in the absence of stimulus.  Interestingly, stimulation with ALS1/3-
deficient strain CJN 1348 resulted in IL-17 levels comparable to those resulting from 
stimulation with WT C. albicans, indicating the existence of other CD4+ T cell epitopes 
that stimulate IL-17 production (Figure 3.7A).  In addition, CD4- and MHC II-dependent 
production of IFN# upon in-vitro re-stimulation was observed (Figure 3.7B), which 
contrasts with the flow cytometry data where Th1 cells were not detected.  However, the 
IFN# levels detected in the in vitro co-cultures are modest (~10-100 pg/ml) compared to 
the large amounts of IL-17 (~500-2000 pg/ml) measured (Figure 3.7).  Therefore, C. 
albicans re-challenge induced primarily CD4+IL-17+ cells in an antigen-specific manner.  
The study of antigen-specific responses in C. albicans infection models has been 
hampered by the lack of reagents such as TCR-specific transgenic mice. To address C. 
albicans-specific T cell responses in vivo during OPC, we created a strain of C. albicans 
that expresses chicken ovalbumin (Candida-OVA) in order to track T cell responses 
using the OTII transgenic system, in which all CD4 T cells express a TCR specific for 
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OVA peptide 323-339 (OVA323-339).  Figure 2.6C-D shows that two of the recombinant 
yeast clones we generated integrated the OVA sequence into the genome and 
expressed OVA protein as measured by ELISA.  Next, it was important to test whether 
recombinant Candida-OVA was recognized by OTII cells in vitro using lymphocyte 
proliferation as readout.  Lymphocyte proliferation was measured by monitoring dilution 
of CFSE, a dye that binds to intracellular proteins and dilutes with every cell division 
(Figure 2.7).  Disappointingly, we observed no proliferation of OTII cells upon Candida-
OVA stimulation, whereas lymphocytes proliferated significantly in the presence of 
OVA323-339 (Figure 3.8A).  In order to ensure that the absence of proliferation of OTII 
cells was not due to denaturation of the OVA protein as a result of the heat killing 
process, we cultured OTII cells in the presence of live Candida-OVA, but no proliferation 
was observed (Figure 3.8B).     
Taken together, these observations indicate that C. albicans re-challenge 
primarily induces IL-17 in a CD4 and antigen-dependent manner.  However, tracking C. 
albicans-specific responses in vivo was not possible due to the fact that our Candida-
OVA did not stimulate in vitro proliferation of OTII splenocytes. 
3.2.5 CD4+ T cells induced upon re-challenge protect Rag1-/- mice from OPC. 
Thus far, we have demonstrated that adaptive immune responses play an important role 
in fungal clearance, presumably due to the induction of Th17 cells upon re-challenge.  
However, these data did not prove that these Th17 cells are directly responsible for 
fungal clearance.  Therefore, we isolated CD4+ T cells from total cLN cells of WT mice 
3 days post 2° infection and adoptively transferred them into Rag1-/- host one day prior 
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to infection.  We observed that Rag1-/- mice that received CD4+ T cells were protected 
from OPC whereas mice receiving CD4- cells were not protected (Figure 3.9A, left 
panel).  We also tracked weight loss post-infection since it is usually a good indicator of 
disease progression.  However, we detected no significant differences between mice 
that received CD4+ T cells and mice that received CD4- or no cells. (Figure 3.9A, right 
panel).  Importantly, the homing of donor CD4+ T cells into the tongue of Rag1-/- mice 
correlated with increased expression of IL-17 as measured by real-time RT-PCR of 
tongue tissue, suggesting that Th17 cells are recruited to the tongue during infection 
and contribute to fungal clearance (Figure 3.9B).  Importantly, we detected no IFN# 
following transfer of Candida-primed cells, confirming our finding that C. albicans-
specific CD4+ T cell responses are primarily Th17. 
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Figure 3.3:  Pre-exposure to C. albicans results in accelerated fungal 
clearance.  Mice were subjected to 1° infection alone or followed by 2° 
challenge (1°+2°).  As a negative control mice received 2 consecutive sham 
infections.  Tongue tissue was harvested and plated for colony enumeration 
at days 1-3 post re-challenge.  Experiment was repeated twice and the 
pooled data from both experiments is depicted. 
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Figure 3.4:  C. albicans re-challenge induces Th17 but not Th1 cells.  (A) 
cLN cells from the experiment described in Figure 3.3 were isolated 1-3 days 
after re-challenge and stained for CD4, IL-17 and IFN#.  Lymphocytes were 
gated on CD4+, and IL-17+ and IFN#+ cell frequencies are depicted.  (B) 
Summary of CD4+IL-17+ cell frequencies (from panel A) normalized to the 
isotype control.  
 
A. 
B. 
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Figure 3.5:  CD27 and CD44 expression on the surface of Th17 cells 
induced upon re-challenge.  cLN cells were isolated 3 days after 1° 
infection or re-challenge and analyzed by flow cytometry for surface 
expression of CD27 and CD44 and intracellular IL-17.  Lymphocytes were 
gated on CD3 and CD4 and the frequencies of IL-17+CD27+, IL-17+CD27-, 
IL-17+CD44+ and IL-17+CD44- cells are depicted as representative FACS 
plots (A) and as a summary of all the data collected (B).  
 
A. 
B. 
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Day 3 
A. 
B. 
Day 3 
Figure 3.6:  CD4+ T cells are the primary source of IL-17 during re-
challenge.  cLN cells were isolated 3 or 5 days after re-challenge and 
subsequently analyzed by flow cytometry.  Lymphocytes were gated on CD3 
and CD4 or CD8 and the frequency of IL-17+ and IFN#+ cells is displayed in 
panel A for one representative mouse and summarized in B for all the mice 
included in this experiment.  
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Figure 3.7:  Th17 cells induced upon re-challenge are antigen-specific.  WT 
mice were subjected to sham, 1° only or 1° + 2° infections and 3 days post re-
challenge 1 x106 cLN cells were re-stimulated in vitro with 2 x 106 HK C. 
albicans or pALS at the specified concentrations in the presence or absence of 
anti-CD4 (5µg/ml) or anti-MHC class II (10µg/ml) blocking antibodies.  The 
strains of C. albicans used were WT CAF 2-1 (depicted as Candida), 
CAYC2QTPU1 (depicted as ALS+/+) and CJN 1348 (depicted as ALS-/-).  5-4 
days after in vitro stimulation, the supernatants were harvested and the 
concentration of IL-17 (A) and IFN# (B) was measured by ELISA. 
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Figure 3.8:  Candida-OVA does not stimulate proliferation of OTII 
splenocytes in-vitro.  (A) OTII splenocytes were labeled with CFSE and 
incubated for 5 days in the absence of stimulus or in the presence of OVA 
peptide (OVA323-339), the parental HK C. albicans strain (no OVA) or HK 
Candida-OVA..  Following incubation the cells were harvested and analyzed for 
CFSE dilution.  Cells were gated on lymphocytes and CD3 vs. CFSE is 
depicted.  (B) Experiment was performed as in (A) with the exception that OTII 
splenocytes were incubated with live C. albicans.  In order to avoid C. albicans 
overgrowth fluconazole was added.  Lymphocytes were gated on CD3+CD4+ 
cells and CD4 vs. CFSE is displayed. 
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Figure 3.9:  CD4+ T cells induced during re-challenge protect Rag1-/- mice 
from OPC and their homing into the tongue associates with increased IL-
17A expression.  WT mice were subjected to sham or 1° and 2° infections and 
cLN were harvested 3 days following re-challenge.  CD4+ and CD4- cells were 
purified by magnetic sorting (positive selection) from cLN cells and transferred i.p. 
into Rag1-/- mice 24 hours prior to infection.  As controls for the infection, Rag1-/- 
that received no cells (PBS) were either sham- or C. albicans-infected.  Five days 
after infection the tongue of Rag1-/- mice was harvested and homogenized for 
both colony enumeration (A, left panel) and relative quantitation of IL-17A and 
IFN# expression by real-time PCR (B).  The weight of Rag1-/- mice was 
monitored every day for the duration of the experiment and it is shown as percent 
of the original weight (A, right panel).  Panels A and B resulted from 3 separate 
experiments. 
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3.3 DISCUSSION 
To the best of our knowledge, this is the first study where the relative role of adaptive 
and innate immune responses to OPC had been addressed.  Furthermore, we 
demonstrated that pre-exposure to C. albicans resulted in accelerated fungal clearance, 
which was associated with the development of long-term C. albicans-specific Th17 
responses.  Even more importantly, Th17 cells induced upon re-challenge protected 
Rag1-/- mice from OPC.  Thus, Th17 cells are an important source of IL-17 during re-
challenge and contribute to fungal clearance. 
Upon pre-exposure to C. albicans, we achieved approximately a 1 log decrease 
in fungal burden, which is a significant finding considering that experimental vaccines to 
C. albicans confer, at most, approximately a 2 log protection.  In fact, the only 
experimental vaccine (recombinant N-terminus of Als3) which efficacy was tested in 
OPC provided less than 1 log protection upon challenge with C. albicans (Spellberg et 
al., 2006).  During disseminated candidiasis, administration of a vaccine that consisted 
of DC transfected with C. albicans RNA resulted in a 5-fold decrease in fungal burden 
when compared to controls (Bozza et al., 2004).  In addition, vaccination with antibody-
inducing preparations of C. albicans cell wall proteins and carbohydrates resulted in, at 
most, a ~2 log decrease in fungal burden following intravenous or intravaginal challenge  
(Casadevall and Pirofski, 2012).  In addition, there are no fungal vaccines currently 
used for treatment.  Therefore, it is difficult to define a quantitatively significant 
protection with no point of reference. 
The accelerated fungal clearance we observed upon pre-exposure to Candida 
was associated with an increase in the frequency of antigen-specific CD4+IL-17+ T cells 
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in the cLN.  My attempt to perform a more detailed study of antigen-specific Th17 
responses was hampered by the observation that Candida-OVA did not stimulate 
proliferation of OTII splenocytes in vitro.  We are not certain of what caused this 
phenomenon.  One possibility is that since OVA was fused to SSA2, a membrane 
protein, it is not secreted.  This could limit the accessibility of APCs to OVA protein and 
thus the OVA323-339 peptide responsible for the activation of OTII cells.  In fact, initial 
studies using DO11.10 TCR transgenic T cells (also specific for OVA323-339) to track in 
vivo T cell responses employed E. coli-OVA, where OVA was fused to a secreted 
protein (Chen and Jenkins, 1998).  However, in a recent elegant study others 
engineered a C. albicans strain where OVA323-339 epitope, and other model antigens, 
were fused in frame to the enolase gene (Calb-Ag), which does not encode a secreted 
protein (Igyarto et al., 2011).  Of note, here they fused the epitope directly, not the 
whole OVA protein, which may have increased the accessibility of APCs to the antigen.  
In fact, Calb-Ag was able to stimulate proliferation of OTII T cells in vitro and, upon 
antigen processing and presentation by Langerhan’s Cells in the skin, induced Th17 
development. 
In spite of the technical difficulties experienced while studying antigen-specific T 
cell responses in OPC, we demonstrated that C. albicans induced CD27-CD44+ Th17 
cells upon re-challenge.  Furthermore, re-challenge-induced CD4+ T cells protected 
Rag1-/- mice from OPC, which correlated with a local increase in IL-17 expression upon 
homing of CD4+ T cells to the tongue of Rag1-/- mice.  Therefore, we believe that when 
Th17 cells encounter C. albicans during re-challenge, they migrate to the tongue and 
cooperate with local innate IL-17 sources to clear C. albicans. 
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4.0  CHAPTER 4: COMPENSATORY SOURCES OF IL-17 DURING C. ALBICANS 
RE-CHALLENGE IN CD4-DEFICIENT MICE 
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4.1 BACKGROUND 
In chapter three it was demonstrated that adaptive immune responses contributed to C. 
albicans clearance from the oral cavity and that fungal eradication was associated with 
an increased frequency of antigen-specific Th17 cells, suggesting that Th17 cells are 
essential for fungal clearance.  This is in accordance with three important observations 
in humans: (1) the majority of C. albicans-specific T cells in peripheral blood exhibit a 
classic Th17 phenotype (CD4+CCR4+CCR6+IL-17+) (Acosta-Rodriguez et al., 2007), 
genetic mutations at various stages of the Th17 pathway (Figure 1.2 and Table 1.1) 
are associated with the development of CMC, (3) Approximately 95% of HIV+ 
individuals develop overt “thrush” lesions and thus, OPC is considered an AIDS defining 
illness (Akpan and Morgan, 2002).  In light of these observations, it was important to 
determine whether Th17 cells were absolutely required for fungal clearance or if other 
components of the adaptive immune system, such as IL-17-producing CD8+ T cells, are 
involved in antifungal host defense. 
Therefore, in this chapter we examine the host response to C. albicans in the 
context of CD4+ T cell deficiency and explore the role of CD4-independent sources of 
IL-17 in antifungal immunity.  It appears that CD8+ T cells induced upon re-challenge of 
CD4-/- mice play a previously unappreciated role in anti-C. albicans immunity.    
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4.2 RESULTS 
4.2.1 CD4-/- mice are resistant to C. albicans re-challenge. 
In order to determine if CD4+ T cells are an absolute requirement for antifungal host 
defense, CD4-/- mice were subjected to re-challenge.  We monitored their weight over a 
period of 5 days post re-challenge, since weight loss is a good indicator of disease 
progression.  We also plated tongue tissue for quantification of fungal burden on day 5 
after 2° infection.  Unexpectedly, CD4-/- mice were resistant to re-challenge and 
completely cleared C. albicans from the tongue (Figure 4.1).  This finding indicated that, 
in our OPC model, CD4+ T cells are not the sole requirement for C. albicans clearance.  
Furthermore, given the importance of IL-17 in antifungal host defense, these data also 
indicated that CD4+ T cells are not solely responsible for IL-17 production and further 
suggested the existence of compensatory sources of IL-17. 
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Figure 4.1:  CD4-/- mice are resistant to OPC.  WT and CD4-/- mice were re-
challenged as described in Figure 2.1 and their weight was monitored for 5 
consecutive days following re-challenge.  On day 5, the tongue was harvested and 
plated for colony enumeration (inset).  Weight data is presented as percent of the 
original weight at the time of infection (Day 0). 
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4.2.2 CD8+ T cells from CD4-/-, but not WT, mice synthesize IL-17 after re-
challenge in an antigen-specific manner. 
The finding that CD4-/- mice were resistant to C. albicans infection prompted us to 
determine whether compensatory sources of IL-17 are present in CD4-/- mice during 
OPC.  We found that in the absence of CD4+ T cells, CD8+ T cells synthesize IL-17 
upon C. albicans re-challenge (Figure 4.2).  Importantly, as shown in Figure 3.6 and 
4.2, CD8+ T cells from WT mice do not produce IL-17.  We also detected CD8+IFN#+ 
cells both in WT and CD4-/- mice but there was no difference between the mice that 
received a sham infection and the mice that were re-challenged.  
In order to gain insight into the antigen specificity of these CD8+IL-17+ cells we 
stimulated total CD4-/- cLN cells with HK C. albicans in vitro following either 1° infection 
alone or 1° and 2° challenges.  Figure 4.3 shows that CD4-/- cLN cells produced as 
much IL-17 as WT cLN cells but only in the presence of HK C. albicans, demonstrating 
that IL-17 production depended on the presence of antigen.  IFN# was also present in 
these supernatant in negligible amounts (Figure 4.3).  These data suggest that CD8+ T 
cells are a compensatory source of IL-17 in the context of CD4+ T cell deficiency. 
In addition, we also tested the susceptibility of CD8-/- mice to C. albicans re-
challenge.  Since CD8-/- mice still possess CD4+ T cells presumably capable of 
producing IL-17 upon re-encounter with C. albicans, we expected CD8-/- mice to be 
resistant to re-challenge.  Indeed, CD8-/- mice were completely resistant to 2° infection 
(Figure 4.4).  As expected, CD4+ T cells produced IL-17 upon secondary infection of 
both WT and CD8-/- mice (Figure 4.5), which correlated with antigen-specific and CD4-
dependent production of IL-17 upon re-stimulation of CD8-/- cLN cells with HK C. 
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albicans (Figure 4.6).    Small amounts of IFN# were also observed in CD8-/- cLN cell 
supernatants.   
 
 
 
 
 
 
 
 
 
 
 
 
A. 
B. 
Figure 4.2:  CD8+ T cells from CD4-/- mice produce IL-17 upon re-challenge.  
WT and CD4-/- mice were re-challenged as in Figure 2.1 and the cLN were 
harvested after 5 days.  Single cells suspensions of cLN cells were analyzed by 
flow cytometry for surface expression of CD3, CD4 and CD8 and intracellular IL-
17 and IFN#.  Lymphocytes were gated on CD3+ cells and subsequently on CD4+ 
or CD8+.  The frequencies of IL-17+ and IFN#+ cells among CD4+ or CD8+ T 
cells is depicted in (A).  A summary the data corresponding to all the mice used in 
this experiment is shown in (B). 
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Figure 4.3:  CD8+IL-17+ cells induced upon re-challenge of CD4-/- mice are 
antigen-specific.  WT and CD4-/- mice were given a sham, 1° only or 1° + 2° 
infections and, after 3 (A) or 5 (B) days, cLN cells were isolated and cultured in 
vitro in the presence or absence of HK C. albicans +/- anti-CD4 blocking 
antibody (5µg/ml).  Following a 5-day incubation period supernatants were 
harvested and analyzed for IL-17 and IFN# production by ELISA.  The data 
depicted in panels (A) and (B) resulted from two different experiments. 
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Figure 4.4:  CD8-/- mice are resistance to OPC.  WT and CD8-/- mice 
were re-challenged as described in Figure 2.1 and their weight was 
monitored for 5 consecutive days following re-challenge.  On day 5, the 
tongue was harvested and plated for colony enumeration (inset).  Weight 
data is presented as percent of the original weight at the time of infection 
(Day 0). 
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B. 
Figure 4.5:  Frequency of CD4+Il-17+ cells in CD4-/- mice post re-
challenge.  WT and CD8-/- mice were re-challenged as in Figure 2.1.  3 to 5 
days post-re-challenge cLN cells were analyzed for surface expression of 
CD4 and intracellular IL-17 and IFN# expression.  Cells were gated on 
lymphocytes, CD3 and CD4.  The frequency of IL-17+ or IFN#+ cells among 
CD4+ T cells is depicted.  Data was normalized to isotype controls.  The data 
depicted in panels (A) and (B) resulted from two different experiments. 
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A. Day 3 
B. Day 5 
Sham Sham Sham Sham Sham Sham 
Figure 4.6:  CD4+ T cells from CD8-/- mice produce IL-17 in an antigen-
specific and CD4-dependent manner.  WT, CD4-/- and CD8-/- mice were 
given a sham, 1° only or 1° + 2° infections and, after 3 (A) or 5 (B) days, cLN 
cells were isolated and cultured in vitro in the presence or absence of HK C. 
albicans +/- anti-CD4 blocking antibody (5µg/ml).  Following a 5-day incubation 
period supernatants were harvested and analyzed for IL-17 and IFN# 
production by ELISA.  The data depicted in panels (A) and (B) resulted from 
two different experiments. 
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4.2.3 Antibody-mediated depletion of CD4+ and CD8+ T cells in WT mice does 
not result in susceptibility to C. albicans re-challenge. 
The use of CD4-/- and CD8-/- mice allowed us to address whether or not compensatory 
sources of IL-17 were present during re-challenge. However, we did not answer the 
question of whether or not simultaneous depletion of both CD4+ and CD8+ T cells 
confers susceptibility to OPC.  An adequate way to address this question was to re-
challenge CD4 and CD8 double knockout (CD4CD8-/-) mice and quantify fungal burden 
in tongue tissue following re-challenge but these mice were not available at the time 
these experiments were performed.  We then decided to deplete CD4+ and CD8+ T 
cells in vivo via injection of depleting antibodies prior to re-challenge.  WT, CD4-/- and 
CD8-/- mice depleted of CD4+ or CD8+ T cells alone or simultaneously were resistant 
to C. albicans re-challenge (Figure 4.7).  This was not due to defective cell depletion, 
as surface staining of splenocytes 5 days after the antibodies were injected 
demonstrated complete depletion of CD4+ and CD8+ T cells (Figure 4.8).  However, it 
is certainly possible that the antibody did not reach the oral cavity and thus, local cell 
depletion was not as effective as peripheral cell depletion, but this hypothesis was not 
tested. 
Our findings confirmed the results presented in Figures 4.1 and 4.4 and indicate 
that even in the context of combined CD4+ and CD8+ T cell depletion mice are still 
resistant to OPC.  This suggested that, in addition to CD8+ T cells, other compensatory 
sources of IL-17 exist and “take over” IL-17 production when CD4+ T cells are absent.  
Furthermore, this also points to the importance of innate sources of IL-17, which are 
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presumably operating in the absence of CD4+ and CD8+ T cells, in host defense 
against OPC. 
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Figure 4.7:  Simultaneous depletion of CD4+ and CD8+ T cells results in 
resistance to OPC. WT, CD4-/- and CD8-/- mice were re-challenged and 
depleted of CD4+ and/or CD8+ T cells as described in Figures 2.1 and 2.4, 
respectively.  Weight was monitored everyday for a period of 5 days after re-
challenge.  Data is presented as percent of initial weight at the moment of 
secondary challenge (Day 0).  
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4.2.4 CD8+ T and CD4-CD8- (DN) cells from CD4-/-, but not WT, mice re-
challenged with C. albicans protect Rag1-/- mice from OPC. 
In light of the apparent resistance of CD4-/-, CD8-/- and T cell-depleted mice to OPC 
and considering the possibility that potent innate IL-17 responses were masking the role 
of adaptive IL-17 responses in OPC, it was important to determine whether C. albicans-
primed CD8+IL-17+ cells protected susceptible hosts from OPC.  Therefore, we isolated 
CD4+, CD8+ and DN cells from WT and CD4-/- mice 3 days after re-challenge and 
transferred them into Rag1-/- mice 1 day prior to infection (outlined in Figure 2.5).  We 
Isotype 
 
Anti-CD4 Anti-CD8 
CD8 
C
D
4 
Injected antibody 
Figure 4.8:  In vivo CD4+ and CD8+ T cell depletion is effective.  CD4+ 
and CD8+ T cells were depleted as described in Figure 2.4 and splenocytes 
were harvested 5 days later and analyzed by flow cytometry for surface 
expression of CD4 and CD8.  The frequency of CD4+ and CD8+ cells among 
lymphocytes is depicted. 
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then enumerated C. albicans colonies in the tongue of Rag1-/- recipients 4 days 
following infection.  Since cLN cells from CD4-/- mice produce IL-17 at  levels equivalent 
to CD4+ cLN cells from WT mice, we hypothesized that the transfer of CD8+ T cells 
from CD4-/- mice following re-challenge would fully protect of Rag1-/- mice from OPC.  
As expected, CD4+ T cells from WT mice conferred Rag1-/- mice with complete 
protection from OPC (Figure 4.9).  CD8+ T cells from CD4-/- mice offered some 
protection but not to the same extent that CD4+ T cells from WT mice.  Surprisingly, the 
DN cell fraction from CD4-/-, but not WT, mice completely protected Rag1-/- mice from 
OPC, suggesting that in addition to CD8+ T cells, other sources of IL-17 can 
compensate for the absence of CD4+ T cells.    
4.2.5 Protective CD4+, CD8+ and DN cells home to the tongue after transfer into 
Rag1-/- mice. 
The protection conferred to Rag1-/- mice by CD4+ T and CD8+ T or DN cells isolated 
from WT and CD4-/- mice, respectively, after re-challenge demonstrated that Candida-
primed cells home to the tongue during infection and actively clear the fungus (Figure 
4.9).  In order to gain more insight into the local immune response during infection, we 
measured the mRNA levels of CD3, CD4 and CD8 in the tongue of Rag1-/- recipients 4 
days following infection post-transfer.  Interestingly, CD3, CD4 and CD8 mRNA levels 
were increased when the transferred population was associated with protection from 
OPC (Figure 4.10), suggesting that these cells home to the tongue after transfer and 
perhaps expand in situ when they re-encounter C. albicans. 
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Figure 4.9: CD8+ T and DN cells from CD4-/- mice protect Rag1-/- mice 
from OPC.  Total CD4+, CD8+ and DN cells were isolated from WT and CD4-
/- mice and transferred into Rag1-/- mice as described in Figure 2.5 1 day 
prior to infection.  4 days after infection C. albicans colonies were enumerated 
in the tongue of recipient Rag1-/- mice.  
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Figure 4.10: Protective CD4+, CD8+ and DN cells home to the tongue upon 
transfer into Rag1-/- mice.  Total CD4+, CD8+ and DN cells were isolated from 
WT and CD4-/- mice and transferred into Rag1-/- mice as described in Figure 
2.5 1 day prior to infection. 4 days after infection the tongue RNA was isolated 
and CD3e, CD4 and CD8 mRNA levels were quantified by real-time PCR.     
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4.2.6 Phenotype of protective DN cells. 
The protective effect of DN cells isolated from CD4-/- mice after re-challenge prompted 
us to study their phenotype in further detail.  The experiment depicted in Figure 4.10 
showed that DN cells are CD3+.  This finding was subsequently confirmed in an 
independent experiment where CD3+DN cells produced IL-17 upon re-challenge only in 
CD4-/- mice (Figure 4.11A).  Of note, we detected no infection-dependent IL-17 
production in WT or CD4-/- CD3- cells (Figure 4.11B).  The only other CD3+ population 
in the lymph nodes is #$ T cells (Turchinovich and Pennington, 2011).  In addition, a 
population of MHC class II-restricted CD4- T cells has been described in CD4-/- mice 
(Tyznik et al., 2004).  Thus, we examined surface expression of #$ and !" on CD3+DN 
cells from WT and CD4-/- mice 3 days following re-challenge.  We also included CD8-/- 
mice in this experiment to determine whether a similar DN cell population was present 
in the context of CD8+ T cell deficiency.  We found no difference in the frequency of #$ 
and !" CD3+DN cells among total cLN cells from WT, CD4-/- and CD8-/- mice following 
re-challenge (Figure 4.11C-D).  In addition, we measured #$ and !" mRNA levels in 
the tongue of Rag1-/- mice that received DN cells from re-challenged CD4-/- mice and 
were subsequently infected with C. albicans.  We found no obvious trend in #$ or !" 
expression that will direct us to the phenotype of DN cells (Figure 4.12).  Therefore, it 
appears that the only apparent phenotypic characteristic of these cells is their 
expression of CD3. 
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Figure 4.11: CD3, #$ TCR and "% TCR expression on DN cells.  WT and CD4-
/- mice were re-challenged and after 5 days the cLN were analyzed for surface 
expression of CD3, CD4 and CD8 and intracellular IL-17 and IFN#.  Cells were 
gated on lymphocytes, CD4-CD8- and CD3+ cells.  The frequency of IL-17+ cells 
among CD3+CD4-CD8- is depicted (A).  Alternatively cells were gated on 
lymphocytes and CD3- cells and the frequencies of IL-17+ and IFN#+ cells are 
depicted (B).  WT, CD4-/- and CD8-/- mice were re-challenged and after 3 days 
cLN were analyzed for expression of !" and #$ TCR among CD3+IL-17+ cells.  
Representative plots are depicted in (C) and the summary of the cumulative data 
is presented in (D).  Experiments in panels (A), (B) and (C-D) resulted from 3 
separate experiments.  
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Figure 4.12: #$ and "% TCR expression in the tongue of infected Rag1-/- 
mice after adoptive transfer of Candida-primed CD4+ T, CD8+ T and DN 
cells.   Rag1-/- mice were adoptively transferred as described in Figure 2.5 
with either naïve or Candida-primed CD4+ T, CD8+ T or DN cells 1 day prior 
to infection.  After 4 days the tongue of recipient Rag1-/- mice was analyzed 
for  expression of !" and #$ TCR. 
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4.3 DISCUSSION 
In this chapter we showed that CD4-/- mice were resistant to OPC and that this was 
associated with the presence of antigen-specific CD8+IL-17+ cells, demonstrating a 
novel compensatory mechanism that comes into action when Th17 cells are absent.  
Furthermore, Candida-primed CD8+ T cells isolated from CD4-/- mice protected 
susceptible Rag1-/- mice from OPC.  In addition, we found that CD3+DN cells from 
CD4-/- and not WT mice also protected Rag1-/- hosts.  These data demonstrated that, 
in the absence of Th17 cells, other cell types can “take-over” IL-17 production and 
contribute to fight infection.  However, the presence of CD8+IL-17+ T cells alone did not 
account for the resistance of CD4-/- mice to C. albicans infection because depletion of 
CD8+ T cells in these mice did not render them susceptible to OPC.  We attributed this 
phenomenon to the presence of strong innate IL-17 sources that functioned to clear C. 
albicans infection.  Whether or not the protective CD3+DN cell population “fits” the 
profile of an innate cell is uncertain and is an important area of future inquiring. 
Our attempts to identify the phenotype of protective DN cells isolated from CD4-/- 
mice were inconclusive.  We established they were CD3+ but did not determine if they 
were !"+ or #$+.  Flow cytometry data indicated that approximately 40-60% and 30-
40% of CD3+IL-17+DN cells were !"+ and #$+, respectively.  However, there were no 
differences in the frequency of !"+ or #$+ CD3+IL-17+DN cells between re-challenged 
WT and CD4-/- or CD8-/- deficient mice.  Thus, in contrast to CD3 expression on IL-
17+DN cells, !" and #$ TCR expression was not an exclusive trait of DN cells from 
CD4-/- mice.  Perhaps a better approach to defining the phenotype of this cell type is to 
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stain the tongue for #$ and !" TCRs via immunofluorescence after transfer of DN cells 
from CD4-/- mice post re-challenge into Rag1-/- hosts.  In spite of the technical 
challenges of defining the phenotype of this cells, we know they home to the tongue and 
protect Rag1-/- mice from OPC, which stresses their importance as compensatory 
sources of IL-17 in CD4-/- mice. 
It was surprising to find compensatory production of IL-17 by CD8+ T cells in 
CD4-/- mice and, even more importantly, that these CD8+IL-17+ cells protected Rag1-/- 
mice from OPC.  This finding is supported by recent studies in a vaccine model of 
Blastomyces dermatitidis infection that described the presence of antigen-specific Tc17 
cells induced upon vaccination in the absence of CD4+ T cell help (Nanjappa et al., 
2012a; Nanjappa et al., 2012b).  Remarkably, vaccination-induced Tc17 cells protected 
mice from lethal pulmonary challenge.  This has important implications in the 
development of antifungal vaccines to benefit immunocompromised individuals, such as 
HIV+ patients, where residual immunity must be harnessed to fight opportunistic 
infections.  Interestingly, studies in HIV+ individuals with OPC revealed that CD8+ T 
cells migrated to the lamina propria of the tongue but, due to a defect in E-cadherin 
expression, did not reach the outer epithelium where C. albicans resided (McNulty et al., 
2005; Myers et al., 2003).  These studies suggested that CD4+ T cells constitute the 
primary line of defense against C. albicans but when counts fall below the protective 
threshold (200 cells/mm3) CD8+ T cells, along with epithelial cells, can then act as the 
“reserve warriors” to fight C. albicans (Fidel, 2011).  These CD8+ T cells that migrated 
to the tongue were activated memory cells but their cytokine profile was not defined.  
Studies in non-human primates indicated that Tc17 cells were present at early stages of 
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SIV infection but their numbers reduced dramatically during end-stage AIDS (Nigam et 
al., 2011).  However, no information was provided regarding the OPC status of these 
SIV+ monkeys and its correlation to the frequency of Tc17 cells.  Therefore, Tc17 
represent a previously underappreciated component of antifungal immunity that should 
be targeted to design vaccines that would benefit both healthy and immune 
compromised individuals. 
Taken together, these findings demonstrate that although antigen-specific Th17 
responses contribute to fungal clearance, their absence is compensated for by CD8+IL-
17+ and CD3+DN cells in CD4-/- mice.  Moreover, these compensatory sources of IL-17 
protected susceptible Rag1-/- mice from OPC and thus, constitute important 
components of antifungal immunity under immune suppressive conditions. 
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5.0  CHAPTER FIVE: MECHANISMS OF IL-17-MEDIATED IMMUNITY 
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5.1 BACKGROUND 
The mechanisms of IL-17 mediated immunity are associated to the induction of 
antimicrobial peptides (AMP) in epithelial surfaces and the mobilization of neutrophils to 
peripheral inflammatory sites.  Pioneering studies of IL-17 in a Klebsiella pneumoniae 
infection model demonstrated that IL-17 is a major inducer of granulopoiesis and 
neutrophil chemotaxis (Ye et al., 2001).  A plethora of studies in other infection systems, 
many conducted long before the recognition of Th17 cells, showed that IL-17 mobilizes 
neutrophils. IL-17 activates neutrophils indirectly, primarily by upregulating expression 
of G-CSF and CXC chemokines in mucosal epithelial cells as well as the local stroma 
(Khader et al., 2009).  With respect to candidiasis, IL-17 appears to mediate many of its 
protective effects via mobilization of neutrophils to peripheral inflammatory sites.  In 
systemic candidemia, IL-17R-deficient mice exhibited decreased absolute neutrophil 
counts in peripheral blood, which correlated with impaired neutrophil recruitment and 
myeloperoxidase activity in the kidney (Huang et al., 2004).  In OPC, both IL-23p19-/- 
and IL-17R-/- mice exhibit decreased neutrophil numbers in the oral mucosa compared 
to resistant mouse strains.  Moreover, microarray analysis of tongue tissue showed 
induction of prototypical IL-17 target genes that serve to expand or recruit neutrophils, 
such as genes encoding CXCL1 (KC, Gro"), CXCL2 (MIP2), CXCL5  and CSF3 (G-
CSF) (Conti et al., 2009).  In addition, C. albicans can stimulate oral epithelial cells to 
secrete CXCL8 (IL-8), another potent neutrophil chemoattractant (Dongari-Bagtzoglou 
and Kashleva, 2003; Dongari-Bagtzoglou et al., 2005).  Similarly, in a murine model of 
VVC 75% of the total vaginal infiltrate at 48 hours post-infection were found to be 
neutrophils, coinciding with elevated IL-17 and IL-23 in vaginal fluid (Pietrella et al., 
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2011).  In addition, it has been demonstrated that "-glucans can induce human 
neutrophil chemotaxis and that neutrophil extracellular traps can capture and kill both C. 
albicans yeast and hyphae (Urban et al., 2006).  Therefore, IL-17-dependent 
recruitment of neutrophils to the site of infection is likely an important element in host 
responses to C. albicans.  
Despite its potent effects on neutrophils, is not clear whether mobilization of 
neutrophils is the primary underlying mechanism by which IL-17 mediates antifungal 
effects. Although patients undergoing chemotherapy associated with neutropenia are 
highly susceptible to various forms of disseminated candidiasis, individuals with isolated 
neutropenia or neutrophil defects such as chronic granulomatous disease (CGD) are 
not particularly prone to Candida infections (Del Favero, 2000; Grigull et al., 2006; 
Maertens et al., 2001).  In this regard, IL-17 induces antimicrobial peptide (AMP) 
expression in a variety of settings, and many of the IL-17-induced AMPs have direct 
antifungal activity towards Candida (Gorr, 2009).  In skin, IL-17 signals cooperatively 
with IL-22 to induce AMPs such as S100A7 and !-defensin 2 (BD2) in keratinocytes and 
epithelial cells (Liang et al., 2006). In humans with HIES, this effect is significantly 
impaired (Minegishi et al., 2007), perhaps explaining the susceptibility to dermal and 
oral candidiasis in these patients.  In VVC, production of BD2 by vaginal epithelial cells 
is inhibited following ablation of Th17 responses (Pietrella et al., 2011).  Moreover, in 
murine OPC, AMP such as S100A8, S100A9 and "-defensin 3 (murine homologue of 
BD2) are induced in tongue in WT mice but impaired in IL-17R-/- animals (Conti et al., 
2009).  Thus it appears that IL-17 mediates its effects primarily by inducing recruitment 
of neutrophils to sites of infection and stimulating production of antimicrobial peptides 
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but which is more important remains unclear to date. 
5.2 RESULTS 
5.2.1 Expression of IL-17 target genes and neutrophil infiltrate in the tongue after 
re-challenge. 
In light of the important role of IL-17 in the induction of antimicrobial peptides and in 
neutrophil homeostasis and chemotaxis, we compared the expression of various genes 
associated with these processes during primary infection and re-challenge.  To this end, 
mice were subjected to 1° infection alone or followed by secondary challenge and the 
tongue tissue was subsequently harvested at days 1,2 and 3 post re-challenge.  As a 
negative control, we included a cohort of naïve mice that received a mock infection.  
Tongue RNA was then extracted and used for cDNA synthesis, which was followed by 
real-time PCR.  We observed that Csf2 (GM-CSF), Csf3 (G-CSF), CXCL1 and CXCL5, 
which are involved in granulopoiesis and neutrophil chemotaxis, were induced on day 1, 
started declining on day 2 and were almost undetectable by day 3 (Figure 5.1).  On the 
other hand, antimicrobial peptides, such as "-defensin 3 and S100A9, were induced on 
days 2 and 3 after both primary infection and re-challenge (Figure 5.1).  No statistical 
differences in gene expression were observed between the mice that received primary 
infection alone and those that were subjected to re-challenge.  Accordingly, no obvious 
differences were observed in the recruitment of neutrophils to the tongue following 1° 
infection only or 1° + 2° challenge as observed by H & E staining of tissue sections 
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(Figure 5.2).  Therefore, although Th17 responses accelerate C. albicans clearance 
(Figure 3.3) and protect susceptible host from OPC, adaptive IL-17 responses are 
superimposed by potent antifungal innate responses. 
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Figure 5.1: Expression of IL-17 target genes in tongue tissue during C. 
albicans re-challenge.  Mice were given a sham, 1° only or 1° + 2° infections 
and the tongue was subsequently harvested at days 1, 2 and 3 post re-
challenge.  Tongue RNA was then isolated and analyzed for mRNA levels of the 
indicated genes.  Data was normalized to GAPDH mRNA levels. 
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Figure 5.2: Histology sections of tongue tissue during C. albicans re-
challenge.  Mice were given a sham, 1° only or 1°+ 2° infections and, at 
days 1-3 post re-challenge, the tongues were harvested, preserved in NBF 
and parafilm embedded for subsequent tissue sectioning.  Tissue sections 
were then stained with H&E for visualization of tongue-infiltrating 
neutrophils and PAS for visualization of C. albicans yeast and hyphae.  
Tongue lesions are indicated with black arrows.  
Figure 5.2 cont  
 91 
5.3 DISCUSSION 
In chapter 1, we determined that pre-exposure to C. albicans resulted in accelerated 
fungal clearance, which was associated with an increase in the frequency of CD4+IL-
17+ cells.  Here we sought to determine whether differential induction of IL-17 target 
genes during re-challenge, in comparison to primary infection alone, could account for 
the 1 log decrease in fungal burden observed at days 1 and 2 post 2° infection.  We 
found no statistical differences in gene expression between the mice that underwent 1° 
infection only and those that received 1° and 2° challenges.  This correlated with a 
similar neutrophil infiltrate in both cohorts at all the time points examined following 
infection.  
The fact that we did not detect any significant differences in gene expression 
upon re-challenge may be due to the potent innate IL-17 responses that superimpose 
on Th17-mediated immunity.  Therefore, anti-Candida innate responses may be 
“masking” the contribution of C. albicans-specific CD4+ T cell responses.  
Although there were no apparent differences in gene expression upon either 
primary infection alone or re-challenge, the gene expression patterns suggests that the 
first “wave” of genes targets neutrophil recruitment to the tongue, whereas the second 
“wave” results in secretion of antimicrobial peptides.  However, to define these patterns 
in detail, a more extensive range of IL-17 target genes involved in neutrophil chemotaxis 
and antimicrobial peptide production needs to be examined.  
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6.0  CHAPTER SIX: CONCLUSIONS AND FUTURE DIRECTIONS 
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6.1 SUMMARY AND CURRENT MODEL OF IMMUNITY TO C. ALBICANS IN OPC 
Our studies demonstrated that pre-exposure to C. albicans accelerated fungal 
clearance following re-challenge by causing a ~1 log decrease in fungal burden.  This 
was associated with an increase in the frequency of antigen-specific CD4+IL-17+ cells, 
suggesting the involvement of classic Th17 cells in fungal eradication from the tongue.  
Surprisingly, however, CD4-/- mice were resistant to OPC, which appeared to be 
associated, at least in part, with the generation of CD8+IL-17+ and CD3+DN IL-17+ 
cells.  Disease resistance in CD4-/- mice could not be exclusively attributed to the 
presence of CD8+IL-17+ because mice depleted of both CD4+ and CD8+ cells are also 
resistant to OPC.  Thus, potent innate IL-17 responses appeared to be responsible for 
resistance to disease.  It is known that this IL-17-producing innate cell requires a 
rearranged receptor because Rag1-/- mice are susceptible to OPC.  In the absence of 
this innate component, such as in Rag1-/- mice, CD4+ and CD8+ T cells from WT and 
CD4-/- mice, respectively confer protection from OPC.  This suggests that, in spite of 
the evident reduction in fungal burden following pre-exposure to C. albicans, innate IL-
17-mediated immune responses are masking the role of classic antigen-specific Th17 
cells.  This was reflected in both neutrophil recruitment and gene expression profiles 
following either 1° infection alone or re-challenge.  Neutrophils were recruited to the site 
of infection on days 1 and 2 after 1° infection or 1° + 2° challenges.  In addition, in both 
cases (1° only or 1° + 2°) IL-17 target genes were expressed in two “waves”.  The first 
“wave” consisted CXCL1, CSF2 and CSF3 with the highest level of expression on day 
1, starting to decline on day 2 and almost completely absent on day 3.  The opposite 
was true for the second “wave” of genes, which consisted of antimicrobial peptides such 
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as S100A/9 and "-defensin 3; they were expressed at the lowest level on day 1 and 
peaked at day 3.  Therefore, regardless of the source of IL-17, whether innate alone or 
accompanied by adaptive Th17 responses, the mechanisms of IL-17-mediated 
immunity appear to be the same.  
In light of these findings, we believe that innate immune responses alone are 
capable of clearing C. albicans from the oral cavity.  Upon pre-exposure to C. albicans 
and thus, the development of adaptive Th17 responses, innate and adaptive responses 
“team-up” to eradicate C. albicans, resulting in accelerated fungal clearance (Figure 
6.1).   
These data highlights the importance of animal models that better resemble the 
human condition, where C. albicans is a commensal and, as a result, the immune 
system is chronically exposed to the fungus.  This constant access to antigen likely 
plays an important role in shaping anti-Candida T cell responses, which are largely 
Th17 mediated.  Another important aspect regarding the commensal nature of C. 
albicans, is the other constituents of the human microflora.  It is known that DCs in the 
lamina propria of the gut extend projections through the epithelium, which allows them 
to potentially interact with commensal microorganisms.  Although the mechanisms by 
which the rich intestinal immune system maintains tolerance to commensal microbes 
while simultaneously providing immunity to infections remains unclear, it is possible that 
these DC-commensals interactions play a role in shaping host immune responses to 
pathogens (Iwasaki and Medzhitov, 2004).  The fact that C. albicans is both a 
commensal and a pathogen (under conditions of immunosuppression) adds an 
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additional and intriguing level of complexity to the study of C. albicans-specific 
responses. 
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Figure 6.1: Current model of immunity to OPC.  In the context of no prior exposure to 
C. albicans, innate immune responses alone can clear infection.  Upon prior exposure to 
C. albicans, adaptive immune responses develop and contribute to fungal clearance.  
The mechanisms of IL-17-mediated immunity employed by both innate and adaptive 
responses are similar, induction of neutrophil chemotaxis and expression of antimicrobial 
peptides.  Arrows indicate gene expression levels.  
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6.2 THE ROLE OF INNATE IMMUNITY IN ANTI-C. ALBICANS HOST DEFENSE 
Our studies demonstrated that innate immunity is an important component of anti-C. 
albicans host defense.  Therefore, identifying innate source (s) of IL-17 during OPC is of 
paramount importance.  The fact that Rag1-/- mice are susceptible to OPC indicates 
that the innate IL-17-producing cell type requires a rearranged receptor.  Thus, #$ T 
cells are interesting candidates because they express a T cell receptor, are abundant in 
mucosal surfaces, like the gut and the skin, play a role in barrier immunity and express 
various pattern recognition receptors (Cua and Tato, 2010).  In fact, IL-17-producing #$ 
T cells were shown to express TLR2 and Dectin-1 and to expand in response to C. 
albicans hyphae and curdland ("-glucan) (Martin et al., 2009).  In addition, IL-17+ #$ T 
cells were found in the skin of mice infected with C. albicans.  The role of #$ T cells in 
OPC is controversial.  An interesting study in nonprogressor HIV+ patients described a 
subset of circulating memory #$ T cells (V$1) that produced IL-17 and IFN# ex-vivo in 
response to C. albicans, suggesting that this subset may compensate for reduced 
numbers of CD4+ T cells and aid in host responses against opportunistic infections 
(Fenoglio et al., 2009), such as OPC.  However, #$ T cell deficient mice were resistance 
to OPC. 
Another potential candidate as a source of Il-17 is iNKT cells, which express a T 
cell receptor and have been demonstrated to play an important role during Aspergillus 
fumigatus infection.  An elegant study demonstrated that mice deficient in CD1d, an 
“MHC-like” molecule that presents lipid antigens to iNKT cells, were susceptible to A. 
fumigatus infection (Cohen et al., 2011).  Interestingly, iNKT cells also recognized C. 
albicans in vitro, suggesting that iNKT cells may play a role in host responses to 
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Candida.  This study did not address whether or not in vitro stimulation with C. albicans 
resulted in IL-17 production by iNKT cells, which is an important question in the context 
of immunity to OPC.  In contrast to what we expected from the aforementioned studies, 
CD1d-deficient mice were resistant to OPC (Alanna C. Peterson, unpublished).  
 Given what we know about compensatory mechanisms of IL-17 production, 
identifying the innate source of IL-17 will require: (1) in situ analysis of the immune cell 
infiltrate by immunofluorescence or immune cell isolation from tongue tissue and 
subsequent staining of cell surface markers to analyze their expression by flow 
cytometry.  This has proven difficult due to the muscular consistency of the tongue and 
its high autofluorescence. 
In addition to innate sources of IL-17, another concept of innate anti-Candida 
immunity that should be explored in OPC is “trained immunity”.  A recent study 
performed in murine disseminated candidiasis demonstrated that Rag1-/- mice, which 
lack B and T cells, were protected from re-infection with a lethal dose of C. albicans, 
suggesting that an innate cell type had the ability to “memorize” its encounter with C. 
albicans and respond upon re-exposure (Quintin et al., 2012).  It was demonstrated that 
this type of “innate memory” was dependent on the epigenetic reprograming of 
monocytes, which resulted in increased production of pro-inflammatory cytokines such 
as IL-6 and TNF!.  Our studies demonstrated that, upon pre-exposure to C. albicans, 
the tongue fungal burden is decreased at days 1 and 2 following re-challenge, which is 
a surprisingly rapid response and, perhaps, suggests the presence of a tissue resident 
innate population with “memory” properties.  Furthermore, protective Th17 cells were 
not detected in cLN until day 3 after re-challenge.  Therefore, the induction of C. 
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albicans-specific Th17 cells does not entirely explain the decrease in fungal burden at 
days 1 and 2 post re-challenge.  The presence of “memory monocytes” during these 
early time points is an intriguing possibility.  In addition, if these monocytes are indeed 
present during OPC, it will be interesting to study how they influence downstream T cell 
responses. 
6.3 WHERE DO WE GO FROM HERE? THE FUTURE OF ADAPTIVE IMMUNITY 
TO CANDIDA ALBICANS 
Recent years have witnessed the development of powerful tools and important 
discoveries that will allow for more comprehensive studies of antigen-specific responses 
to C. albicans.  The engineering of the OVA-expressing C. albicans (Calb-Ag) and the 
discovery of the pALS epitope permit the in vivo tracking of T cells during infection (Bar 
et al., 2012; Igyarto et al., 2011).  For example, adoptively transferring OVA-specific T 
cells into WT mice followed by infection with Calb-Ag will permit detailed dissection of 
the kinetics of antigen-specific responses in the tongue tissue following infection.  
Furthermore, labeling of these OVA-specific T cells with tracking dyes, such as CFSE, 
will be instrumental in imaging studies to determine the location and spatial 
arrangement of antigen-specific T cells in the tongue.  This will provide important 
information about the interaction of these T cells with other members of the immune 
system in the oral mucosa, which is largely understudied.  In addition, the identification 
of pALS as a CD4+ T cell epitope opened the door to many possibilities.  It is possible 
to synthesize MHC class II tetramers bearing the pALS peptide, which will be invaluable 
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for studying C. albicans-specific responses ex-vivo by flow cytometry.  Furthermore, a 
TCR transgenic mouse where the T cells are pALS-specific will be a much-needed tool 
in the study of CD4+ T cell responses during Candida infections.  
Another aspect of anti-Candida CD4+ T cell-mediated immunity that disserves 
careful consideration is the stability of the Th17 phenotype.  A significant body of 
evidence has demonstrated that CD4+ T helper subsets are not fixed entities and rather 
exhibit considerable “plasticity”, which is driven by epigenetic changes and is influenced 
by the surrounding microenvironment.  For example, Tregs can convert to Th17 cells 
and Th17 cells in turn have the capacity to convert into Th1 and Th2 cells (Hirahara et 
al., 2011; O'Shea and Paul, 2010).  In the context of C. albicans infections, in vitro 
studies showed that dendritic cells activated via dectin-1 convert CD25+Foxp3+ Tregs 
into Foxp3+ROR#T+IL-17+ cells in an IL-23-dependent manner (Osorio et al., 2008), 
suggesting that Tregs aid the pro-inflammatory process and thereby fungal clearance.  
Accordingly, the co-transfer of in vitro polarized Th17 and Treg cells prevented Rag1-/- 
mice from developing OPC (Pandiyan et al., 2011).  However, whether or not C. 
albicans induces Tregs in vivo remains to be determined and, if this is the case, do 
these cells remain as T regs or do they convert to Th17 cells?  In addition to the Treg to 
Th17 conversion, Th17 to Th1 conversion has also been reported in some settings.  In 
fact, memory CD4+ T cells double positive for IL-17 and IFN# expression were detected 
following in vitro stimulation of human PBMC with C. albicans (Zielinski et al., 2012).  
On the other hand, elegant in vivo studies using fate-tracking mice demonstrated that 
both Th17 cells and #$+IL-17+ cells induced upon C. albicans skin infection exhibited a 
stable phenotype because no IL-17+IFN#+ cells or “ex-Th17” cells were detected 
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(Hirota et al., 2011).  This has not been studied in OPC but Th17 to Th1 conversion 
seems unlikely since we and others have shown that Th1 and IL-17+IFN#+ cells are 
absent from the cLN following re-challenge.  However, our studies included early time 
points after re-challenge (Days 1-3) and Th17 to Th1 conversion later during infection is 
possible.    
In light of these observations, it appears that the mechanisms of adaptive 
immunity to C. albicans are only beginning to be unraveled and more detailed studies 
are needed in order to aid antifungal vaccine design and the effective treatment of 
fungal infections.  
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